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ABSTRACT 
 In addition to providing heat insulation and mechanical cushioning, 
adipose tissue regulates overall metabolic homeostasis and serves as an 
essential energy storage site. Excess adipose tissue, or obesity, is on the rise in 
the US among all demographics. The expansion of adipose tissue results from 
both adipocyte hypertrophy and hyperplasia but the mechanisms that regulate 
these processes are not fully understood. Destabilizing actin has been shown to 
promote adipogenesis while actin stabilization inhibits this process. In addition, 
decreased actin synthesis is known to occur. However, these studies examined 
total actin and did not consider that actin is in fact a family of functionally diverse 
isoforms and that individual isoforms may have different functions in 
adipogenesis. I hypothesized that actin isoforms contribute differently to 
adipogenic actin reorganization. To measure this, I developed a novel 
fractionation method that allowed for the reliable quantification of actin 
polymerization. I used this actin fractionation method to identify an early loss in 
polymerized α-smooth muscle actin (α-SMA) relative to polymerized β-actin and 
γ-actin and to also rule out a role for the actin severing protein gelsolin in the loss 
of polymerized actin. Furthermore, I showed that the loss of α-SMA expression 
  viii 
precedes the loss of β-actin and γ-actin expression. A known regulator of actin 
cytoskeleton genes is the transcription factor serum response factor (SRF) and 
its co-activator, myocardin related transcription factor (MRTF). I identified a role 
for MRTF/SRF in the downregulation of actin expression during adipogenesis, 
particularly α-SMA. There was an additional cAMP-responsive decrease in α-
SMA expression during the initiation of adipogenesis by exposure to established 
inducers. Overall, my findings are consistent with growing evidence suggesting 
that genetic markers of smooth muscle cells, including α-SMA, help control 
adipogenic commitment. Understanding these early stages of adipogenesis could 
open new therapeutic avenues for obesity and its co-morbidities. 
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CHAPTER ONE 
MATERIALS AND METHODS 
Mice 
 Whole adipose tissue and primary stromal vascular cells were isolated 
from wild type C57Bl/6 mice and from MRTFA+/+ and MRTFA–/– mice (1). All 
MRTFA+/+ and MRTFA–/– mice also expressed Collagen-GFP and Smooth 
muscle actin-mCherry which was inbred by crossing MRTFA+/- mice with mice 
with only Collagen-GFP transgene or both transgene (C57BL/6J background) 
(Kalajzic et al., 2005; Kalajzic et al., 2008). All mice were generously genotyped 
and raised by Dr. Chendi Li and Dr. Hejiao Bian (Boston University School of 
Medicine). 
Isolating stromal vascular fraction cells (SVC) 
 Epididymal or inguinal fat pads were dissected from mice and minced into 
small pieces. Tissue was digested in 1-2 mg/mL Type 1 Collagenase 
(Worthington, CLS1) in DMEM containing 4.5 g/L glucose (Mediatech, Inc.) and 
2% bovine serum albumin (American Bioanalytical) while shaking in a 37°C 
incubator. Digested tissue was filtered through a 100 μm mesh and centrifuged at 
500xg for 10 min. Adipocytes and the underlying supernatant were then 
aspirated and the stromal vascular fraction pellet was resuspended in DMEM 
containing 4.5 g/L glucose (Mediatech, Inc.) supplemented with 10% fetal bovine 
serum (FBS) (Atlas) and plated on tissue culture-grade dishes. The resulting 
 
 
 
2 
stromal vascular cells (SVC) were cultured at 37°C in a 5% CO2 environment. At 
confluence, cells were induced to differentiate in DMEM supplemented with 10% 
FBS, 5 uM dexamethasone, 0.5 mM isobutylmethyl xanthine and 0.86 mM 
insulin. After two days of induction, cells were maintained in DMEM containing 
10% FBS and 0.86 mM insulin until the time of harvest. 
Cell culture 
 3T3-L1 cells were cultured in DMEM supplemented with 10% calf serum 
at 37 °C in a 5% CO2 environment. At confluence, cells were induced to 
differentiate in DMEM supplemented with 10% FBS, 5 uM dexamethasone, 0.5 
mM isobutylmethyl xanthine and 0.86 mM insulin. Two days after induction, cells 
were maintained in DMEM containing 10% fetal bovine serum and 0.86 mM 
insulin until the time of harvest. C3H10T1/2 cells were cultured in DMEM 
supplemented with 10% FBS at 37 °C in a 5% CO2 environment. 3T3-L1 cells 
and C3H10T1/2 cells were purchased from the American Type Culture Collection 
(Manassas, VA). 3T3-L1 cells GR knockdown cells were a kind gift from the lab 
of Dr. Susan Fried, Boston University School of Medicine. They were created 
with lentivirus delivery of short hairpin RNA (shRNA) targeted to the murine GR 
or non-targeting shRNA (2).  
Treatments 
 Dulbecco‟s Modified Eagle‟s Medium (DMEM) containing 4.5 g/L glucose 
(Mediatech, Inc; Herndon, VA) was supplemented with 10% fetal bovine serum 
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(Atlas Biologicals, Fort Collins, CO). Dexamethasone, indomethacin, 3-isobutyl-
methylxanthine and T3 were purchased from Sigma-Aldrich (St. Louis, MO). 
Recombinant insulin and TRIzol reagents were purchased from ThermoFisher 
Scientific (Pittsburgh, PA). RNEasy Plus Kit was purchased from Qiagen (Hilden, 
Germany). Acti-Stain 488 Phalloidin was purchased from Cytoskeleton, Inc 
(Denver, CO). TGFβ1 was purchased from R&D Technologies (North Kingstown, 
RI). Halt protease inhibitor cocktail was purchased from Pierce (Rockford, IL).  
Small molecule compounds were purchased as listed: CCG1423 (Cayman 
Chemical Company, Ann Arbor, MI), Y27632 (Sigma Aldrich, St. Louis, MO), 
jasplakinolide (Tocris Bioscience, Bristol, UK), swinholide A (Enzo), latrunculin A 
(Cayman Chemical Company, Ann Arbor, MI)  
Transfections 
 3T3-L1 cells were transfected with 10 nM small interfering RNA (siRNA) 
targeting gelsolin (Ambion, 4390771) or 10 nM Control siRNA-A (Santa Cruz 
Biotechnologies. sc-37007). They were also treated with 30 nM siRNA targeting 
MRTF-A (Santa Cruz Biotechnologies, sc-149641) or 30 nM eGFP siRNA 
(EGFP-S1 DS Positive Control, Integrated DNA Technologies). Transfections 
were performed using DeliverX siRNA transfection kit (Affymetrix) according to 
manufacturer‟s instructions in subconfluent, proliferating 3T3-L1 cells. 
3T3-L1 cells were transiently transfected with plasmid using Lipofectamine 
3000® (Invitrogen). DNA-lipid complexes were produced per manufacturer‟s 
instructions and cells were transfected for 24 hour before harvest or subsequent 
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experimental steps.  Cells were transfected with a plasmid containing full-length 
mouse alpha smooth muscle actin with an N-terminal mCherry tag (mCherry-
Alpha-Actin2-C-18, 54973) and its empty vector (mCherry2-C1, 54563), both 
purchased from Addgene, and with a GFP-tagged MRTFa construct or its 
corresponding empty vector (provided by Dr. Matthew Layne, Boston University 
School of Medicine). All plasmids were purified using Pure YieldTM Plasmid 
Midiprep System (Promega, A2492) according to manufacturer‟s instructions. 
Quantitative RT-PCR RNA analysis 
 Total cellular RNA was isolated using TRIzol reagent (Life Technologies) 
or with the RNEasy Plus Kit (Qiagen). To generate cDNA, the High Capacity 
DNA Reverse Transcription Kit (Applied Biosystems) was utilized per the 
manufacturer‟s instruction and with 0.5-1.0 ug of total cellular RNA. Quantitative 
RT-PCR was performed in 96-well plates using the Maxima SYBR Green 2x 
qPCR Master Mix (Thermo Fisher) in the ABI Prism 7300 sequence detector for 
the following program: initial denaturation at 95 ͦC for ten minutes, followed by 40 
PCR cycles, with each cycle consisting of a denaturation step for 15 seconds at 
95 ͦC, a 20 second annealing step at 60 ͦC, and a 30 second elongation step for 
30 seconds.  
 SYBR green fluorescence emissions were monitored at the end of each 
cycle. For each gene, mRNA expression was calculated relative to the 
expression of TATA binding protein (TBP) mRNA or cyclophilin A mRNA 
expression. Amplification of specific transcripts was confirmed by melting-curve 
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profiles (cooling the sample to 68°C and heating slowly to 95°C with 
measurement of fluorescence) at the end of each PCR. Primer sequences used 
for q-PCR analysis are listed in Table 1. 
Immunofluorescence staining 
 Cells were fixed at room temperature in 3.75% formaldehyde for 10 
minutes then rinsed with PBS briefly. Cells were then permeabilized in 0.2% 
TritonX-100/PBS for 5 min at room temperature. After a brief PBS rinse, cells 
were incubated in 3% BSA/PBS (American Bioanalytical) for 30-60 min at room 
temperature to block specific binding of antibodies before staining with primary 
antibodies in 0.02% Triton X-100/PBS overnight at 4⁰C.  Primary antibodies used 
include mouse monoclonal antibodies to β-actin (1:200 dilution; A5441; Sigma-
Aldrich), α-SMA (1:200 dilution; A5228; Sigma-Aldrich). Cells were rinsed three 
times at room temperature with 0.02% Triton X-100/PBS, 10 minutes per rinse. 
Immune complexes were detected with Alexa Fluor 568–conjugated goat anti-
mouse IgG (1:200 dilution; A11031; Life Technologies) following 60 minute 
incubation at room temperature. Cells were rinsed three times at room 
temperature with 0.02% Triton X-100/PBS, 15 minutes per rinse. F-actin was 
stained with AlexaFluor 488–phalloidin (Molecular Probes, 1:200) in PBS, and G- 
actin was stained with Alexa Fluor 594–labelled DNaseI (Molecular Probes, 
1:500) in PBS. After a brief rinse in distilled water, cells were mounted onto slides 
to be simultaneously counterstained with SlowFade Gold antifade reagent with 
DAPI (Invitrogen, S36938). Cells were observed with either a Leica SP5 point- 
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Target Forward Reverse 
MRTFa AGGACCGAGGACTATTTGAAACG CCACAATGATAGCCTCCTTCAG 
CEBPβ GCAAGAGCCGCGACAAG GGCTCGGGCAGCTGCTT 
Acta2 GATCAGCAAACAGGAATAC CCAGGGCTACAAGTTAAG 
Actb TTACTGCTCTGGCTCCTA AAACGCAGCTCAGTAACA 
Actg1 CACACACAGTGCCCATCTAT GACCGAGCCACATGAACTAA 
TBP CCAAGCGATTTGCTGCAGTCATCA ACTTAGCTGGGAAGCCCAACTTCT 
GILZ TGTGGTGGCCCTAGACAACAAGAT TGGGAGTTCTTCTCAAGCAGCTCA 
GR TCAGGCAGATTCCAAGCAG CTGTGGGTAGCCCAAGTCAT 
Pref1 GGATTCGTCGACAAGACCTG GCTTGCACAGACACTCGAAG 
Mical2 AAGATGACGCTGTGGAGAAC GGGCAATGTGAGGTTGAGATA 
PPARγ TCAGCTCTGTGGACCTCTCC ACCCTTGCATCCTTCACAAG 
Adiponectin TGTTCCTCTTAATCCTGCCCA CCAACCTGCACAAGTTCCCTT 
KLF4 GAAATTCGCCCGCTCCGATGA CTGTGTGTTTGCGGTAGTGCC 
UCP-1 ACTGCCACACCTCCAGTCATT CTTTGCCTCACTCAGGATTGG 
CideA TGCTCTTCTGTATCGCCCAGT GCCGTGTTAAGGAATCTGCTG 
Gelsolin GGTGATGCCTATGTCATCCTAAA AGAGCCACACCACTGATAGA 
Cofilin TGCTCTTTCTGTCTCCCTTTC CTTGCTCTCCTTGGTCTCATAG 
Destrin CAAGGAGTCCAGGAAAGAAGAG GCTGGATTTAGGTAGGGTAGTG 
Cyclophilin A TGGAGAGCACCAAGACAGACA TGCCGGAGTCGACAATGAT 
 
Table 1. qPCR primer sequences   
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scan confocal microscope or a Nikon light phase microscope, Model TMS (120V, 
50/60 Hz, 0.4 A, 50 W). 
SDS-PAGE and Western analysis 
 To harvest protein lysates, cells were washed three times with cold PBS 
and scraped in lysis buffer containing 25 mM Tris (pH 7.4), 50 mM sodium 
chloride, 0.5% sodium deoxycholate, 2% NP-40, and 2% sodium dodecyl sulfate 
(SDS) HaltTM protease inhibitor cocktail (ThermoFischer). The lysates were  
incubated on ice for 20 min and centrifuged at 12000 x g for 10 min. The 
supernatant was collected and used for analysis.  
For SDS-PAGE analysis, cell lysate extracts were quantified by the BCA 
method (Pierce™ BCA™ Protein Assay Kit, PI-23225, Thermo Scientific™) 
against a bovine serum albumin (BSA) protein standard curve. Equivalent 
amounts of protein (between 10 and 30 µg) were denatured in 5x sample buffer 
containing 10% SDS, 0.5 M DTT, 0.2 M Tris pH 6.8, 50% glycerol, and 0.5% 
bromophenol blue for 5 min at 95°C. The samples were then run on 10%/12% 
Mini-PROTEAN TGX Gels (Bio-Rad) or gels cast in-house (Ultra Pure ProtoGel, 
National Diagnostics) in a running buffer of 25 mM Tris, 192 mM glycine, and 
0.1% SDS. Gels were run at a constant potential of 80 V for until the 
bromophenol blue ran off the gel. Once the samples were run on the gel, protein 
was transferred onto polyvinylidene fluoride membranes (Biorad) in transfer 
buffer containing 48 mM Tris pH 8.3, 39 mM glycine, 0.037% SDS, and 20% 
methanol. 
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Membranes were blocked in 5% milk-PBST for 1 hour at room temperature. 
Membranes were then washed 3 times in PBST and probed with primary 
antibodies (Table 2) overnight at 4°C. Following incubation with primary antibody, 
blots were washed 3 times in PBST, incubated with either anti-rabbit IgG-
horseradish peroxidase (HRP) (Sigma, 1:5000), anti-mouse IgG-HRP (Sigma, 
1:2000) or anti-goat IgG HRP (Santa Cruz, 1:10000) for 1 h at room temperature, 
washed 3 times in PBST, incubated with HYGLO ECL substrate kit (Denville) and 
developed using film or a Bio-Rad ChemiDoc imaging system. Protein 
quantification was measured using ImageJ software.  
CSK/RSB fractionation 
 For all CSK/RSB fractionation, cells were grown to a confluent monolayer. 
For cells grown in 60 mm cell culture dishes, 300 μL of CSK and RSB buffers 
with HaltTM protease inhibitor cocktail (ThermoFischer) were used. Alternatively, 
cells grown in 6-well plates, 250 μL buffer was used per well. Cells were washed 
two or three times with cold PBS while sitting on ice. CSK buffer was added 
gently at the edges of the plate or well. CSK buffer was evenly distributed with 
gentle rocking then set on ice to rotate at ≤15 rpm for 2-15 minutes. Plates were 
then angled to allow for the collection of the buffer without disrupting the cell 
monolayer and briefly rinsed in one third the volume of the same buffer type. 
RSB was added to the plate and the remains of the monolayer were scraped. 
The scraped RSB fraction was vortexed vigorously. All fractions were then spun 
at 12000 x g for 10 min. The supernatant was collected and used for analysis. 
 
 
 
9 
 
Table 2. Primary antibodies    
Protein 
specified 
Manufacturer Catalog 
number 
Application 
(Concentration) 
α-SMA Sigma-Aldrich  A5228 1:2000 
β-actin Sigma-Aldrich  A2228 1:2000 
γ-actin Santa Cruz Biotechnologies sc-65635 1:1000 
Pan actin Cytoskeleton Inc  AAN01 1:500 
Ap2 Cell Signaling Techonologies  35445 1:5000 
PPARγ Cell Signaling Techonologies  sc-7273 1:1000 
C/EBPβ Santa Cruz Biotechnologies sc-150 1:1000 
C/EBPδ Santa Cruz Biotechnologies sc-151 1:1000 
α-tubulin Cell Signaling Techonologies  11H10 1:1000 
Vimentin Santa Cruz Biotechnologies  sc-32322 1:1000 
RNA 
Polymerase II 
Upstate CTD4H8 1:750 
MRTFa Santa Cruz Biotechnologies sc-21558 1:200 
Gelsolin Santa Cruz Biotechnologies  sc-6405 1:200 
GILZ Santa Cruz Biotechnologies sc-33780 1:1000 
Cyclophilin A EMD Millipore 07-313 1:5000 
Adiponectin ThermoFisher PA1-054 1:1000 
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Statistical analysis 
 Results are presented as mean ± SEM. Statistical differences were 
determined by a Student‟s two-tailed t test with equal variance or paired. A P-
value of ≤ 0.05 was considered statistically significant. 
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CHAPTER TWO 
INTRODUCTION 
The importance of adipose tissue 
 Adipose tissue is the most abundant tissue in the body, comprising 10-
29% of body weight (3). It plays several roles in mammalian physiology, the most 
classic of those being energy storage. Additional roles include the regulation of 
glucose homeostasis, thermal insulation and hormone signaling (4). The function 
of adipose tissue varies by type of which there are three: brown adipose tissue 
(BAT), brown-in white (brite)/beige and white adipose tissue (WAT) (5-8). Below 
is a discussion of each type of adipose in detail. Because our studies 
predominately focus on WAT, it is introduced last to facilitate appropriate further 
discussions. 
Brown adipose tissue 
 During the first years of human life, BAT is widely distributed across all 
areas of the human body (9). The regression of BAT post-infancy was thought to 
indicate an absence of BAT in human adults (10,11). In the early 2000‟s, 
metabolically active BAT was identified in adults using F-fluorodeoxyglucose (F-
FDG) absorption during positron emission tomography/computed tomography 
(PET/CT) (6,12). In adults, BAT is largely found in the supraclavicular region and 
neck but can also be found in the paravertebral region, mediastinum, para-aortic 
region and the cardiac apex (13). It should be noted that in rodents classical BAT 
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(i.e. interscapular) is present throughout life (14). These discoveries spurred 
renewed interest in brown fat biology, pushing our understanding of this unique 
form of adipose.  
 BAT catabolizes energy in the form of fatty acids and has been shown to 
be a powerful sink for the draining and oxidation of glucose and triglycerides from 
blood (14). The most common adipocyte in BAT, the brown adipocyte, can 
catabolize fatty acids in mass thanks to a high density of mitochondria, the site of 
β-oxidation (15-17). Mitochondrial abundance visibly darkens the coloring of 
these adipocytes, hence “brown”.  These mitochondria express a protein unique 
to BAT, uncoupling protein-1 (UCP-1) (18). First isolated in 1980, UCP-1 is a 
proton transporter that uncouples electron transport from ATP synthesis (18,19). 
The energy that would otherwise go into ATP during electron transport is instead 
dissipated as heat, making BAT thermogenic (3,18,20).  
 BAT thermogenic activity is not constitutive but, instead must be activated. 
Cold exposure activates BAT to generate heat in order to maintain thermal 
homeostasis (21).  Cold exposure leads to a pronounced increase in BAT mass 
via adipogenesis, an increase in total UCP-1 protein levels and an increase in 
mitochondrial density (22,23).  Cold temperatures stimulate the sympathetic 
nervous system to release catecholamines, which act upon β-adrenergic 
receptors whose downstream effectors activate lipolysis, β-oxidation and drive 
UCP-1 expression (24-27). Because BAT is highly innervated and vascularized, 
thermogenesis can be rapidly activated and efficiently distribute heat released by 
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brown adipocytes for delivery to vital organs (24,28). Catecholamines may also 
be secreted locally by certain subtypes of macrophage and activate BAT (29).  
 It is generally considered that adipocytes originate from the mesoderm 
during embryonic development (14). BAT develops during fetal life, whereas 
WAT grows mainly after birth.  It was once considered that brown and white 
adipocytes shared a common progenitor that diverges at later in development 
(30). A progenitor cell expressing the homeobox transcription factor Engrailed 1, 
though, has been shown to develop into three types of tissue, dermis, muscle, 
and (BAT), to imply that brown adipocytes share an origin with myocytes (31). 
Furthermore, intrascapular and perirenal brown adipocytes depots and skeletal 
muscle were found to share a progenitor expressing myogenic factor 5 (Myf5), a 
master transcriptional regulator of skeletal myogenesis (32).  
 Another proposed brown adipocyte progenitor marker is Early B-Cell 
Factor 2 (Ebf2), which was shown by Seale and colleagues to recruit the nuclear 
hormone receptor peroxisome proliferator-activated receptor γ (PPARγ) to brown 
fat-selective target genes (33). PPARγ and the PPAR family are later discussed 
in detail. It is also possible that brown adipocyte commitment has less to do with 
a specific progenitor profile and more to do with specific inductive signals. Tseng 
and colleagues isolated a progenitor cell capable of becoming WAT, BAT or 
skeletal muscle, where bone morphogenic protein 7 (BMP7) treatment selectively 
drives brown adipocyte commitment, a reminder of how mitogenic signaling helps 
regulate brown adipocyte fate commitment as well (34).  
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Brite/beige adipose tissue 
 In 1984, Ashwell and colleagues identified brown-like adipocytes 
expressing UCP-1 after cold acclimation in perigonadal WAT, which made up 6% 
of WAT pad weight (35). Countless studies since have shown brown-like, UCP-1+ 
islands can arise in specific WAT depots, islands which we now refer to as brite 
or beige adipocytes (8,36). Their presence can be induced by cold (35), PPARγ 
agonism (36) and β-adrenergic receptor stimulation (37). A growing list of agents 
including cardiac natriuretic peptides, fibroblast growth factor 21 (FGF21) and 
retinaldehyde dehydrogenase have been shown to induce brown adipocytes in 
both BAT and WAT (38). FGF21 increases UCP-1 expression in both 
subcutaneous WAT and BAT (39,40). Beige/brite UCP-1 protein levels increase 
to a thermogenically functional level making these adipocytes metabolically 
relevant (41). UCP-1 and T-box 15 (Tbx15), a member of the T-box family of 
homeodomain transcription factors are genes common to beige/brite and BAT, 
while the expression of other BAT-specific genes in brite/beige is mixed 
depending upon the approach utilized to activate and isolate beige/brite 
adipocytes (36,42,43).  
The origins of beige/brite adipocytes are unclear.  Despite shared 
morphological and biochemical characteristics with BAT, beige/brite adipocyte do 
not arise from the Myf5+ lineage of classical brown adipocytes and are thus their 
own form of adipose (44,45). Some speculate that beige/brite adipocytes arise 
from the transdifferentiation of preexisting white adipocytes (46,47). Alternatively, 
 
 
 
15 
beige/brite adipocytes could arise from the differentiation of an unidentified 
progenitor. It‟s possible that these processes are not mutually exclusive. One 
study found that β3-adrenergic activation induces beige/brite adipocytes in 
epididymal WAT through the differentiation of precursors, whereas it induces 
transdifferentiation in inguinal WAT (48). Further complicating the delineation of 
adipocyte progenitors is the identification of Pax3, a transcription factor that 
functions upstream of Myf5, as a marker for conceivably all shades of adipocytes 
(49). Based on the lineage tracing study of Pax3, the authors proposed that 
brown, white and beige adipocytes have multiple and overlapping developmental 
origins.  
 Currently, there is increasing interest in the targeting of brown and 
beige/brite adipocytes as therapies for obesity and metabolic disorder (50). 
Correlations between these forms of adipose and obesity in have been made. 
When BAT is either transiently or permanently ablated via a transgenic toxigene, 
mice become obese even in the absence of overeating (51). BAT negatively 
correlates with BMI and basal metabolic indexes and is also more common 
among females than males (6). As a therapy, expanding these depots will not be 
sufficient since UCP-1 alone does not increase respiratory activity; there must be 
systemic activation (52). Activation has been mimicked by treating mice with β-
adrenergic activators such as CL 316,243 (44,47,53). However, treatment of 
humans with β-AR agonists has not proven to be a viable option because of off-
target effects, poor pharmacokinetic properties and poor oral bioavailability (54). 
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White adipose tissue 
 Compared to BAT and beige/brite adipose, WAT is abundant in the human 
body. WAT depots are largely either subcutaneous, i.e in the buttocks, thighs and 
abdomen, or visceral, i.e. around the omentum, intestines and perirenal areas 
(55). Differences in fat cell size are depot-specific: in humans, the subcutaneous 
adipocytes are usually larger than adipocytes in visceral depots (56). WAT 
adiposity differences also arise between genders. Women are usually more 
obese as a group than men. Men tend to accumulate excess fat within the 
abdominal cavity and, consequently, often have significantly higher mean waist 
circumference (57). Intra-abdominal WAT is strongly associated with type II 
diabetes and with cardiovascular disease, while subcutaneous depots seem to 
protect against these conditions (58). Interestingly, expansion of subcutaneous 
WAT, what‟s referred to as “pear-shape” in humans, does not carry as much risk 
as visceral WAT expansion (59). Such WAT differences could help explain 
gender-specific mortality rates. 
 White adipocyte progenitors are thought to reside within the stromal 
vasculature of adipose, the heterogeneous pool of all non-adipocyte cells (60). 
Within the stromal vasculature, they arise from the mural cell compartment, 
which generally refers to smooth muscle cells and pericytes (61). Adipocyte 
progenitor cell profiles vary by WAT depot. Progenitors from subcutaneous WAT 
differentiate more readily than those from visceral WAT, a consequence of their 
distinct needs in tissue culture conditions (62). General observations have been 
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made about white adipocyte progenitors despite this. Lineage tracing with the 
PPARγ promoter, specifically, has revealed that white adipocytes progenitors 
likely commit to the adipocyte lineage prenatally and continue to divide and 
maintain the progenitor pool in mature mice (61). In a fluorescence-activated cell 
sorting study, a CD24+ cell population in the stromal vasculature was found to 
proliferate and differentiate into functional adipocytes capable of reconstituting 
fully functional adipose in vivo (63).  
Obesity and metabolic disorder 
 Excess adiposity, or obesity, is a condition quantified epidemiologically as 
a body mass index (BMI) greater than 30 kg/m2 (64). Obesity is an expansion 
particularly of WAT, which can lead to WAT can comprising >40% of body weight 
of in an obese human (65). For those under the age of 40, obesity produces few 
symptoms (66). With time, obesity frequently leads to metabolic diseases and 
increases the likelihood of myocardial infarction, stroke and several major 
cancers. Before the 1900‟s, obesity was rare and malnourishment was common, 
driving up the incidence of infectious diseases such as tuberculosis (67). Today, 
roughly 35% of US adults are classified as obese (68). 
 As mentioned previously, adipose tissue is an energy storage site. Upon 
excess caloric intake, energy is largely stored by adipose tissue in the form of 
triglycerides (69). This biochemical process, described over 50 years ago by 
Kennedy and colleagues, converts glycerol-3-phosphate into triglycerides in a 
series of steps (70). The mobilization of adipose energy stores is achieved 
 
 
 
18 
through lipolysis, a sequence of actions by hydrolytic enzymes called lipases that 
work to convert triglycerides into free fatty acids, which fuels peripheral tissues 
upon metabolic demand (71).  
 When the storage limits of adipose tissue are exceeded, lipid begins to 
accumulate in peripheral tissues causing metabolic syndrome. Metabolic 
syndrome is a condition of intertwined metabolic abnormalities including obesity, 
dyslipidemia (elevated circulating lipids), hyperglycemia (elevated blood 
glucose), hyperinsulinemia (elevated circulating insulin), and insulin 
resistance (72). The causal relationship between adipose dysfunction and 
metabolic syndrome remains unclear. Perhaps two of the most popular theories 
revolve around low grade inflammation and adipokines, hormones produced 
largely by adipose (73). Chronic low grade inflammation, which often 
accompanies the accumulation of excess lipid in adipose tissue, increases the 
levels of pro-inflammatory cytokines that then go on to negatively affect systemic 
insulin sensitivity (74,75). Since the discovery of the first adipokine, leptin, 
adipose adopted the role of endocrine organ (76-78). The involvement of 
adipokines in metabolic syndrome centers around changes in their circulating 
levels.  
 With so many associated disorders, it is little wonder why obesity is a 
public health threat. An investigation into medical spending in 2008 found that 
10% was associated with obesity and that obese patients incurred 41.5% higher 
costs relative to healthy weight counterparts (79). To address these issues 
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through public health initiatives will take time and massive social change. In the 
interim, we need to understand the biological origins of obesity in the hopes of 
identifying therapeutic targets.  
Hypertrophy and hyperplasia 
 Obesity is the result of increases in adipocyte size (hypertrophy) and/or 
adipocyte number (hyperplasia). White adipocyte hypertrophy can occur in 
magnitudes that far exceed what other cell types can achieve. The adipocytes of 
healthy human adults can change volume 20-30 fold (80). Hypertrophy can 
disappear almost as quickly as it can appear. It is observed in both early onset 
and late onset obesity, while hyperplasia is only observed in early onset obesity 
(58). Hypertrophy has been cited to be a consequence of diet while hyperplasia 
is a consequence of genetics (81).  
 Because adipocytes are post-mitotic, it is accepted that hyperplasia in 
adipose tissue reflects de novo adipogenesis even in adults (82). However, fat 
cell numbers stay constant among lean and obese adults, even after weight loss, 
to suggest that adipocyte number is set during childhood (83). Instead, 
adipocytes experience high turnover in adults under what is likely a tightly 
controlled system (83). Given our limited progenitor knowledge, understanding 
hyperplasia and adipocyte renewal presents some challenges. What we do have 
is a fair understanding of the process by which progenitors become adipocytes.   
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Models of adipogenesis 
 Much of what we know about adipocyte formation, called adipogenesis, 
was characterized within cell culture models. These models fall into two classes: 
mutlipotent stem cell lines and preadipocyte cell lines. Of the mutlipotent stem 
cell lines, C3H10T1/2 cells are most widely known and used in the study of 
adipocyte, chondrocyte, osteoblast and myoblast lineage commitment. These 
cells were derived from C3H mouse embryos in the 1970‟s and are sensitive to 
postconfluence inhibition of cell division (84). Additional multipotent stem cell 
lines include Balb/c 3T3, 1246, RCJ3.1 and CHEF/18 fibroblasts (85).  
 Preadipocyte cell lines are unipotent and will spontaneously differentiate 
into a morphological and biochemical profile fitting of white adipocytes after 
weeks of culture (86). The most widely used preadipocyte cell line is the 3T3-L1 
cell line which was derived from murine embryonic Swiss 3T3 clones (87). While 
they are subconfluent and proliferative, 3T3-L1 cells are much like fibroblasts. 
They are homogenous and can be passaged rather indefinitely, two 
advantageous features of these cells.  
 Primary cell cultures, namely stromal vascular cells (SVC), are also used 
to study adipogenesis. SVC are derived from the fractionation of adipose tissue 
into an adipocyte pool and a non-adipocyte pool, also called the stromal vascular 
fraction (SVF), that each make up 50% of adipose tissue (88). SVF is a 
heterogenous pool of cells including endothelial cells, mural cells, monocytes, 
mast cells, macrophages, fibroblasts and preadipocytes (89). The process of 
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plating SVF to yield SVC reduces heterogeneity by selecting against the non-
adherent hematopoietic stem pool (90). SVC display mutlipotency, capable of 
differentiating into osteoblasts, chondrocytes, myoblasts and adipocytes both in 
vitro and in vivo (91). When radiolabelled DNA was detected to progress from the 
SVF to adipocytes helped prove preadipocytes reside within adipose tissue (92). 
Cell sorting can reduce the heterogeneity of the SVF pool, but there is no 
consensus on reliable surface markers. Additionally, the propensity of SVC to go 
through adipogenesis varies by adipose depot. In rats, SVCs from subcutaneous 
WAT differentiate better than SVCs from visceral WAT (93). Despite that, the use 
of SVC is well accepted for investigation early steps leading to adipogenic 
commitment. 
The process of adipocyte formation 
 For most cell culture models, adipogenesis proceeds in specific stages. 
First, the cells reach confluence to elicit a period of growth arrest. Studies by 
Pairault and Green demonstrated that growth arrest, not cell-cell contact is 
requisite for adipogenesis (94). Growth arrested cells can be maximally induced 
to become adipocytes by treatment with a mixture of “hormonal” inducers. These 
inducers include isobutylmethylxanthine (IBMX or MIX) which elevates 
intracellular cyclic AMP (cAMP), the synthetic glucocorticoid dexamethasone, 
insulin which interacts with insulin-like growth factor 1(IGF-1) receptor and, lastly, 
fetal calf serum (85). Collectively, these agents are referred to as adipogenic 
cocktail or DMI and the period of time cells receive this treatment is referred to as 
 
 
 
22 
hormonal induction. Preadipocytes synchronously re-enter the cell cycle (G0 to 
G1) and undergo approximately two rounds of mitosis referred to as mitotic clonal 
expansion (95). The preadipocytes then exit the cell cycle and enter into an 
unusual growth arrest called GD. These now committed cells undergo terminal 
differentiation marked by production of lipid droplets as well as the induction of 
multiple metabolic programs characteristic of mature fat cells (96). The induction 
of these metabolic programs is regulated by two major transcription factors, 
PPAR and CCAAT/enhancer-binding proteins (C/EBP), which are discussed 
below. 
PPAR and adipogenesis 
 PPAR is a member of the nuclear hormone receptor superfamily. Nuclear 
hormone receptors bind their respective ligand(s) with both high affinity and 
specificity. This superfamily includes receptors that bind steroid hormones, 
thyroid hormones, vitamin D, and retinoic acid among others (97). They 
recognize short DNA motifs, termed hormone response elements (HRE), usually 
located in the upstream promoter region of the target gene (98). The binding of 
the ligand-receptor complex to its respective HRE activates the transcription of 
specific genes, making nuclear hormone receptors ligand-dependent 
transcription factors (97).  
 In 1990, Issemann and Green identified a new member of the nuclear 
hormone receptor superfamily through cDNA cloning: PPAR (99). PPAR was 
found to be activated by certain hypolipidemic drugs, plasticizers, and herbicides 
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that cause proliferation of peroxisomes, hence the name peroxisome proliferator 
activator receptor (99). There are three members of the PPAR family: PPARα, 
PPARγ and PPARδ. They contain highly conserved DNA-binding domains but 
more divergent ligand-binding domains (100). Although many tissues co-express 
PPAR isoforms, PPARγ is expressed at high levels in the adipose tissue and is 
considered the master regulator of adipogenesis (101,102). 
 PPARγ exists as two isoforms, PPARγ1 and PPARγ2. PPARγ1 is more 
broadly expressed whereas PPARγ2 expression is limited to adipose tissue 
(103). Although PPARγ2 genetic ablation can be compensated by PPARγ1, 
PPARγ2 is considered the key isoform for adipogenesis (103). In general, PPARγ 
overexpression in fibroblasts drives adipogenesis, as long as a synthetic ligand is 
available, while its absence essentially blocks adipogenesis (104,105). PPARγ 
has been shown to be required for the development of both white and brown 
adipocytes (106). When ligand bound, PPARγ heterodimerizes with the 9-cis-
retinoic acid receptor (RXR) to bind a common consensus response element 
dubbed the PPAR response element (PPRE). PPREs consist of a direct repeat of 
two hexanucleotide recognition motif (PuGGTCA) spaced by one nucleotide 
(Direct repeat-1, DR1) and are common to hundreds of adipogenic genes thus 
allowing PPARγ to regulate adipogenesis (96,107). Several synthetic PPARγ 
ligands are known, like thiazolidinediones, but the naturally occurring ligand 
remains unknown.  
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C/EBP and adipogenesis 
 C/EBP is a family of ubiquitous leucine zipper transcription factors named 
after their ability to bind the CCAAT DNA motif (108). Its C-terminal region 
confers the ability to bind DNA and to form dimers, so called leucine zippers, with 
themselves or with other C/EBP members of the family (109). Since the cloning 
of the first C/EBP gene, C/EBPα, the C/EBP has grown to include C/EBPβ, 
C/EBPδ and C/EBPγ among others (108).  
 Several C/EBP isoforms play important roles in adipogenesis. The 
C/EBPβ and C/EBPδ isoforms work as a unit in the activation of C/EBPα (110). 
C/EBPα expression is sufficient to induce growth arrest and adipocyte 
differentiation (111,112). The genetic ablation of C/EBPα or a combined ablation 
of C/EBPβ and δ is sufficient to significantly attenuate adipogenesis (109). Like 
PPARγ, C/EBPα plays an important role in terminal differentiation (113). In fact, 
most PPARγ target genes are bound by both PPARγ and C/EBPα to suggest that 
they cooperatively orchestrate adipogenic gene expression (114).Together they 
form a positive feedback loop that maintains the expression of each in the mature 
adipocyte along with adipogenic genes (96).  
ECM and adipogenesis 
 We have discussed the major internal events and players driving 
adipogenesis, but the extracellular environment also plays a role. The 
extracellular matrix (ECM) is the non-cellular component of tissue and among its 
functions it serves as scaffolding that holds cells together (115). Cells and ECM 
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profoundly influence one another and their interaction is influenced by ECM 
chemical composition, organization and mechanical properties (116). Some of 
the major fibrous-forming proteins of the ECM include collagens, elastin, 
fibronectin, laminins, glycoproteins, proteoglycans, and glycosaminoglycans 
(117,118).  
 An important subset of ECM is the basement membrane (BM). In adipose 
tissue, the BM is a thin layer of laminin, collagen, nidogen/entactic and 
proteoglycans that surrounds and supports adipocytes (119). During 
adipogenesis, preadipocytes locally degrade the BM and alternatively synthesize 
new BM as they mature (120). In culture, this begins with fibronection that is then 
degraded and replaced early during differentiation with collagen types III, V, VI 
and lastly collagen I is laid down at late stage differentiation (120,121). 
Adipogenesis not only influences the ECM but is also influenced by the ECM. 
Treatment with ethyl-3,4-dihydroxybenzoate (EDHB), a specific inhibitor of 
collagen synthesis, reduces adipogenic potential as indicated by lowered 
triglyderide accumulation (122).  
 There is increasing evidence to suggest that adipocytes are 
mechanosensitive, much like hosts of other cell types (123-125). Preadipocytes 
cultured on surfaces that match the rigidity of adipose tissue were found to be 
more insulin responsive (126). Surfaces made rigid by fibronection were also 
found to reduce lipogenic gene exrpression (127). Mechanical deformation of 
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human adipocytes was found to change gene expression, particularly 
inflammatory genes (128). 
Mediating the communication of the ECM and cell are integrins, which bind to 
both ECM proteins and linkage to the actin cytoskeleton. The actin cytoskeleton 
will be discussed in detail in a later chapter.  Integrins are found in clusters 
known as focal adhesions, which are typically approximately  2 µm wide and 3–
10 µm long (129). ECM derived forces transmitted to integrins causes assembly 
and growth of focal adhesion complexes (130). This is regulated by the Rho-
family of small GTPases and their downstream effectors, namely such as Rho-
associated protein kinase (ROCK).  The process of cell adhesion to the ECM 
activates Rho but in stably adhered cells Rho activity declines to a baseline 
(131). 
Rho/ROCK signaling 
 The Rho family of GTPases (RhoA, Rac1 and Cdc42) has been primarily 
associated with cytoskeleton rearrangements, but we now appreciate the 
complex functions of this family (132). It can stimulate a variety of processes, 
including morphogenesis, migration, cell division and adhesion (133). The family 
of Rho proteins interacts with and activates downstream effector proteins when 
bound to GTP. When bound to GDP, Rho is inactive. The cycling between 
GTP/GDP is regulated by three sets of proteins, guanine nucleotide-exchange 
factors (GEFs), GTPase-activating proteins (GAPs) and guanine nucleotide-
dissociation inhibitors (GDIs) (133). All eukaryotes contain at least one Rho 
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GTPase. Microinjection of the Rho GTPase subfamily (RhoA/B/C), was found to 
induce actin stress fiber formation in Swiss 3T3 fibroblasts (134).  
 The first  Rho downstream effector of Rho identified was ROCK (Rho-
associated coiled-coil forming kinase) (Rho kinase/ROCK), it is also the mediator 
of Rho-induced actin cytoskeletal changes (135). The ROCK isoforms, ROCK1 
and ROCK2, are serine/threonine kinases that assume open, active 
conformations upon interacting with GTP-bound Rho (136). These isoforms 
share a high amino acid sequence identity, yet the two kinases only share 65–
70% sequence identity across their PH domains, which may account for their 
observed functional differences (137).  
 ROCK1 is the most ubiquitous and it phosphorylates and activates LIM 
kinase, which goes on to phosphorylate and inactivate cofilin (135). Cofilin is an 
actin binding protein that severs polymerized, filamentous actin (F-actin) (138). 
Thus Rho activity stops the severance of F-actin to indirectly promote actin stress 
fibers. This modulation of actin polymerization has profound effects on the cell; 
first and foremost, it causes cell spreading. In this pathway, then ECM stiffness 
imposes different degrees of cell spreading and, indirectly, cell fate (139). Before 
discussing how Rho/ROCK, actin and additional downstream effectors influence 
adipogenesis in particular, a discussion of actin and its dynamics is needed.  
Actin 
 Actin is the largest organelle in the eukaryotic cell. Its functions are varied 
and essential. Actin is also the most abundant protein and is highly conserved 
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across species, belonging to a superfamily that includes sugar kinases, 
hexokinases, and Hsp70 proteins (140). The structure centers around two major 
domains, α and β. These domains interact very little and as a result create two 
clefts (141). The smaller cleft is lined with hydrophobic residues which interact 
well with actin binding proteins. The larger cleft binds ATP/ADP which is 
essential for actin dynamics.  
Actin dynamics 
 Actin is very dynamic and readily reponds to stimuli. Part of what allows 
actin to be so dynamic is its ability to polymerize and depolymerize 
simultaneously, a process called treadmilling. One end of the actin filament is the 
site of depolymerization, referred to as the minus or pointed end, and the other 
end is the site of polymerzation, referred to as the plus or barbed end (142). 
ATP-bound G-actin joins the filament at the plus end. The ATP-bound state is 
more stable than the ADP-bound state so when ATP hydrolysis occurs, ADP-
bound G-actin readily dissociates from F-actin from the minus end (141). These 
polar processes can occur simultaneously, mimicking a conveyor belt or 
treadmill.  
 Polymerization kinetics alone cannot account for the real-time dynamics 
known to occur in cells. It turns out that the dynamics of G-actin and F-actin is 
tightly regulated in time and space by a large number of signaling, scaffolding 
and actin-binding proteins (ABPs) (143).  ABPs facilitate filament nucleation, 
elongation, severing, capping, and crosslinking and also G-actin sequestration. 
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By one estimate, 162 distinct and separate ABPs have been identified, not 
including their various isoforms (144). Some ABPs have known roles in 
adipogenesis. For example knockdown of Arp2/3, an ABP that promotes 
branching, inhibits adipocyte differentiation (145). Its expression is required for 
efficient GLUT4 trafficking in the mature adipocyte.  
The actin gene family 
 What is broadly referred to as actin, in fact, a family of genes originally 
classified into two groups based upon their N-terminal amino acid sequences: the 
nonmuscle (also referred to as Class I or cytoplasmic) and the muscle (also 
referred to as Class II) isoforms (146,147). These isoforms show tissue specific 
enrichment and are considered  functionally distinct (148). Despite this, they 
share no less than 93% amino acid sequence homology (149). As a general 
reference, Table 3 describes key attributes of all six mammalian actin isoforms 
(149,150). It should be noted that based on its amino acid sequence, γ-smooth a 
Class II based on its enrichment in smooth muscle tissues. To better describe 
their functional diversity, knockout and overexpression systems of Class I and 
Class II isoforms are discussed below.  
 The cytoplasmic isoforms, β-actin and γ-actin, are ubiquitous yet present 
in different proportions depending on cell type and stage of differentiation (146). 
These isoforms differ by only four biochemically similar amino acids, all of which 
are found in the 10 N-terminal residues (149). Despite their similarities, β-actin 
and γ-actin are functionally distinct. Genetic ablation of β-actin but not γ-actin  
 
 
 
30 
  
Table 3. Actin isoforms 
A summary of key attributes for all six actin isoforms common to mammals  
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causes death during embryonic development, although γ-actin-/- mice die within 
48 hours of birth due to respiratory failure and cannibalization by their parents 
(149,151). The β-actin isoform is enriched at the leading edge of migrating 
endothelial and 3T3 cells (152).  In C2 myoblasts, overexpressed β-actin neatly 
integrates into the well-defined filamentous organization of actin (153). Similar 
observations have been made of γ-actin. Overall, the cytoplasmic isoforms are 
both important in cell growth, migration and survival but likely contribute 
differently to these processes. The muscle isoforms includes α-cardiac, α-
skeletal, α-smooth muscle and γ-smooth muscle and gain their names from the 
tissue they are enriched within. Genetic ablation of the α-cardiac-actin is 
embryonic lethal owing to profound disorganization of cardiac myofibrils despite 
compensating expression by other muscle isoforms; genetic ablation of α-
skeletal-actin is also embryonic lethal (149,154). Interestingly, genetic ablation of 
α-smooth muscle actin is not lethal (155). These mice are viable despite defects 
in vascular contractility and blood pressure homeostasis. Overall, actin isoform 
knockout and overexpression models across both classes demonstrate the 
functional diversity among the actin gene family.  
Mechanotransduction and adipogenesis 
 The Rho/ROCK pathway has been implicated in the initiation and 
progression of adipogenesis. Dominant-negative RhoA commits mesenchymal 
stem cells to the adipocyte lineage but only under extracellular conditions that 
limit spreading and promote rounding (156). Overexpression of RhoA is sufficient 
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to block adipogenesis; Rho activity has also been observed to be downregulated 
during the course of adipogenesis (157). In mature, primary adipocytes both 
mechanical stimuli and hypertrophy activate Rho/ROCK to suggest that 
mechanical stretch of the plasma membrane of adipocytes in general promotes 
Rho/ROCK activity even at maturity (119). Rho/ROCK signaling influences cell 
fate and adipogenesis because it regulates the activity of transcriptional 
complexes, particularly Taz/Yap and MRTF/SRF. 
Taz/Yap 
 The functional importance of Taz (transcriptional coactivator with PDZ-
binding motif) and its paralog Yap (Yes-associated protein) is emphasized by the 
embryonic lethality of Yap knockout (158). Taz/Yap activity is largely regulated by 
the Hippo pathway. The Hippo pathway gains its name from the Drosophila 
counterpart of a primary protein kinase involved in the pathway, Hippo (Mst1/2) 
(159,160). The pathway is comprised of a series of phosphorylations:  Mst1/2 
phosphorylates Lats1/2, another pair of kinases that then phosphorylate Taz/Yap 
(161). Phosphorylated Taz/Yap is sequestered in the cytoplasm by its interaction 
with the protein 14-3-3 (162). In the absence of Lats1/2 kinase activity, 
unphosphorylated Taz/Yap can translocate to the nucleus where it influences 
transcriptional activity. Taz/Yap activity, overall, was identified as suppressing 
tissue overgrowth (163). Its exact transcriptional activity will be discussed 
following a discussion of how Taz/Yap is regulated by ECM, Rho/ROCK and 
actin.  
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 As discussed previously, when ECM and integrins interact in focal 
adhesions and this activates Rho/ROCK which drives stress fiber formation. 
Picclo and colleagues demonstrated that Rho and the actin cytoskeleton are 
required to maintain nuclear Taz/Yap and their inhibition was sufficient to inhibit 
Taz/Yap transcriptional activity (164). Specifically, Taz/Yap is predominantly 
nuclear on stiff substrates, while soft substrates promote cytoplasmic Taz/Yap 
localization. Stress fiber formation, then, drives Taz/Yap nuclear localization and 
transcriptional activity. They went on to further show that Taz/Yap regulation 
serves as a link between ECM integrity and cellular function, in that applying 
mechanical stress through defined cell shapes and sizes controls Taz/Yap 
activity (165). Overall, these observations complement the observed role of 
Taz/Yap as major regulator of cell density control. Under low density, then, the 
observed cytoplasmic accumulation of Taz/Yap and the enrichment of F-actin are 
no longer coincidental but causal (166,167). It should be noted that in addition to 
Rho/ROCK signaling, Yap/Taz are regulated by Wnt signaling, G-protein coupled 
receptors and metabolic pathways such as mevalonate biosynthesis, energy 
stress, autophagy and glycolysis (168). 
 Active, nuclear Taz/Yap regulates transcription factors including TEADs, 
Pax3, MyoD, Runx2 and PPARγ (161). Given the previously discussed roles for 
both Pax3 and PPARγ in the development of adipocytes, Taz/Yap is undoubtedly 
involved in adipogenesis. Taz expression at both the protein and transcript levels 
is known to transiently decrease during 3T3-L1 adipogenesis due to 
 
 
 
34 
glucocorticoid receptor activity (169). Overexpression of Lats2 in 3T3-L1 cells 
has been shown to enhance both Taz/Yap phosphorylation and adipogenesis 
(170). Because Taz interacts with PPARγ to repress its downstream target gene 
expression, Taz knockdown in mesenchymal stromal cells is proadipogenic 
(171). Since Taz/Yap mediates levels of Wnt signaling, it could possibly influence 
adipogenesis by modulating the activity of the Wnt signaling pathway, which is 
known to modulate mesenchymal stem cell fate by the magnitude of its activity 
(96,161).  
MRTF/SRF 
Rho/ROCK activity has also been shown to modulate the activity of serum 
response factor (SRF), a MADS (Mcm1 and Arg80 in yeast, Agamous and 
Deficiens in plants, and SRF in animals)-domain containing transcription factor 
(172). SRF is essential for development since genetic ablation of SRF causes an 
absence of mesodermal cells in the embryo (173). SRF binds a palindromic 
CC(A/T)6GG DNA sequence known as the CArG box in the promoters of 
hundreds of target genes (172). In addition to regulating „immediate early‟ genes 
activated by mitogenic stimuli like serum, SRF also regulates tissue-specific 
genes (174). SRF regulates a large volume of gene subsets by interacting with 
over 60 different cofactors (175).  
Myocardin related transcription family (MRTF) is one such family of SRF 
co-factors comprised of myocardin, MRTFa and MRTFb. Myocardin is exclusive 
to cardiac tissue and a subset of SMCs within the cardiovascular system while 
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MRTFa and MRTFb are ubiquitous and homologous (176). Treisman and 
colleagues were the first to describe the regulatory relationship between 
cytoplasmic G-actin and MRTF (177). MRTF binds G-actin under conditions 
where the G-actin pool is enriched relative to the F-actin pool. This sequesters 
MRTF in the cytoplasm. Actin polymerization allows MRTF to translocate to the 
nucleus and co-activate SRF. The Rho/ROCK-LIM kinase-cofilin axis activates 
MRTF/SRF transcriptional activity by driving actin polymerization (Figure 2.1).  
 Although global MRTFb deletion is embryonic lethal, global deletion of 
MRTFa is not lethal (178). Instead, MRTFa deletion causes defects in the 
mammary myoepithelial cells which inhibits proper offspring nursing (178). The 
WAT of MRTFa-/- mice have been shown to contain more brite/beige adipocytes 
(179). Expression of functionally inactive MRTF was sufficient to enhance 
adipogenesis in C3H10T1/2 cells (179). In mouse dedifferentiated fat cells, 
MRTFa was found to antagonize PPARγ transcriptional activity during early 
adipogenesis (180).  
Significance and research goals 
Hyperplasia contributes to the expansion of adipose tissue during obesity. 
Targeting hyperplasia as a treatment for obesity is becoming possible as we 
better understand both the progenitors and commitment steps leading to 
hyperplasia. Mechanotransduction signaling pathways like MRTF/SRF and 
Taz/Yap are known regulators of cell fate. As a regulator of these pathways, actin 
cytoskeleton dynamics plays a major role in cell fate, and in particular adipogenic  
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Figure 2.1 The regulation of MRTF/SRF activity 
A schematic representation depicting the relationship between Rho/ROCK, actin and MRTF/SRF. 
In the active, GTP-bound state Rho/ROCK promotes the polymerization of actin and MRTF can 
locate to the nucleus and co-activate SRF. When the G-actin pool outweighs the F-actin pool, 
MRTF binds G-actin which sequesters MRTF in the cytoplasm, inhibiting MRTF/SRF activity.  
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commitment. Although actin is a functionally diverse gene family, the 
contributions of the individual actin isoforms are not well understood in the 
context of adipogenesis. 
The goal of this study was to describe the expression and dynamics of the 
actin gene family during adipogenesis. We initiated this study with a new 
approach to biochemically assessing actin dynamics. Current commercially 
available biochemical assays of F-actin/G-actin were not rigorous enough for our 
anticipated use so we developed a fractionation method that is easier to perform, 
takes less time to complete and is more reliable to interpret. We then used this 
method to explore a potential mechanism for the loss of F-actin during 
adipogenesis. Our observations prompted us to further investigate actin dynamic, 
which revealed interesting patterns in the loss of F-actin and G-actin. Lastly, we 
identified key differences in the expression and regulation of actin isoforms, 
particularly α-SMA. This study adds to a growing body of evidence suggesting 
major roles for actin and its distinct isoforms in cell fate determination. 
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CHAPTER THREE 
A METHOD FOR THE BIOCHEMICAL ASSESSMENT OF ACTIN DYNAMICS 
Abstract 
 The state of the actin cytoskeleton helps dictate the overall state of the 
cell, making the measurement of actin dynamics important in the study of cell 
biology. Current biochemical methods like G-actin/F-actin fractionation kits 
provide little in the way of normalizing controls and are cumbersome to conduct. 
The goal of this set of studies was to establish a simple, time effective, cost 
effective, yet accurate alternative to the commercial kits. Because G-actin and F-
actin have different solubilities, we hypothesized that brief and sequential 
incubations of cells in distinct buffers would be sufficient to fractionate these actin 
pools. We demonstrated that cytoskeleton buffer (CSK) and reticulocyte standard 
buffer (RSB) can efficiently solubilize G-actin and F-actin, respectively. 
Furthermore, we were able to identify additional proteins that make for reliable 
fraction markers and normalizing controls. We also demonstrate that this 
fractionation method can indeed be used to describe actin dynamics in a number 
of adherent, fibroblastic cell types. 
Introduction 
 The actin cytoskeleton contributes immensely to the fate and function of 
cells at all stages of development. Stem cell fate can be altered by mechanical 
properties such as tensile strain, extracellular stiffness and oscillatory flow (181). 
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As part of the scaffolding of the cell, the actin cytoskeleton mediates the 
communication of these mechanical properties of the cell. This mediating role of 
actin has been corroborated by studies where pharmacologically and 
mechanically alterations were shown to effect mesenchymal and embryonic stem 
cell fate (156,182). Even when cell fate is established, the actin cytoskeleton 
continues to play a role in the identity and functionality of the cell. For example, 
the actin cytoskeleton undergoes dramatic and requisite reorganization during 
the process of epithelial-mesenchymal transition (EMT) (183). Actin and its 
dynamics therefore contribute immensely to cell fate and to over all cell biology.   
 Unlike most other proteins, actin can be studied independent of the cell. In 
vitro studies have yielded great insight into the mechanics of actin dynamics. 
Without the context of the cell, though, we can only understand how actin 
dynamics works but not why or when it works. Actin within the cell has been 
studied using electron or fluorescence microscopy.  Aside from spatially 
describing actin organization, these technologies also have the ability to describe 
the degree of polymerization. The equipment and training required can present a 
steep barrier to their use.  
 Alternatively, fraction kits can be used to biochemically describe actin 
dynamics. Cytoskeleton Inc‟s G-actin/F-actin In Vivo Assay Kit (Cytoskeleton, 
Inc., Denver, CO) is one such kit currently on the market. The assay revolves 
around the use of two extraction buffers: one for the extraction of G-actin, the 
other for F-actin. In between, the extracts must be centrifuged at high speed for 
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nearly an hour to pellet cellular debris. The fractions can be probed for actin 
protein expression through Western blot analysis. Based on our experience with 
the kit, the cellular debris pellet contains signficant amounts of actin (data not 
included). To quantifiably analyze the data, the sum of the optical densities from 
the G-actin and F-actin fractions is treated as total cellular actin (184). F-actin 
and G-actin are then expressed as a percent of that total. 
 Total actin protein levels can change as readily as actin polymerization. 
Actin gene expression is regulated by a transcriptional complex, MRTF/SRF. 
This complex can only drive actin expression when MRTF is within the nucleus. 
Whether MRTF is in the nucleus is determined by the actin cytoskeleton since G-
actin binds and sequesters MRTF in the cytoplasm (185). Provoking actin 
depolymerization or polymerization, be that through drugs or other experimental 
parameters, will ultimately change actin protein levels.  In the published use of 
the G-actin/F-actin In Vivo Assay Kit (Cytoskeleton, Inc., Denver, CO) actin 
protein levels are not normalized (186-188). Although some publications include 
a separate total protein control, it is not used as an external point for 
normalization and may not, in fact, be sufficient (189). Unaddressed changes in 
total actin protein levels may be falsely intepretted as changes in polymerization. 
The fractions cannot be reliably probed for additional markers, eliminating the 
possibility for internal normalization.  
 We have identified a need for a reliable and simple approach to 
biochemically describe F-actin/G-actin dynamics. Fractionation-based 
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approaches are ideal because they can be analyzed via Western blot, an 
accessible biochemical technique. We then needed to determine what 
property(ies) would distinguish the fractions. Based on their biochemical 
properties, cytoskeletal proteins present interesting patterns of solubility. 
Intermediate filament polymers are more insoluble than microfilament and 
microtubule polymers (190). Very little soluble intermediate filament is present in 
most cells whereas only half of the actin in a cell is found to be insoluble (191). 
Microtubules are unique in that they are temperature sensitive, depolymerizing 
into tubulin dimers in the cold and spontaneously reassembling in the warmth 
(192,193).  
 These distinctions in the solubility of cytoskeletal proteins present an 
opportunity to study F-actin and G-actin in a novel way. We hypothesized that G-
actin and tubulin dimers can be isolated independent of both F-actin and 
intermediate filaments by using buffers with distinct stringencies. We identified 
CSK as a candidate for G-actin solubilization. First described in a 1963 study of 
polyribosomes, CSK has since been used to remove cytoplasmic proteins in a 
broad range of cells including fibroblasts (194,195). CSK contains Triton X-100, a 
non-ionic, non-denaturing detergent that does not disrupt native protein 
interactions. It interacts with hydrophobic regions of the plasma membrane and 
renders it porous. Sawasdichai and colleagues developed a method for the use 
of CSK in the visualization of nuclear structures (196). In their study, K562 cells 
incubated in CSK were void of cytoplasmic proteins yet contained DAPI-positive 
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nuclei. Incubating cells in cold CSK should gently pierce the plasma membrane 
to solubilize G-actin and newly depolymerized microtubules.  
 By virtue of its biochemistry, CSK does not solubilized the cytoskeletal 
framework, consisting largely of polymerized actin and intermediate filaments. In 
astrocytes, the intermediate filament protein vimentin is resistant to extraction by 
low salt, non-ionic detergent buffers like CSK (197). With the plasma membrane 
porous, we hypothesized that the low ionic strength detergent buffer RSB could 
solubilize the remaining framework proteins. RSB contains deoxycholate, an 
anionic detergent that effectively disrupts and dissociates protein interactions. 
RSB has long been used to fractionate cells down to the nuclear matrix. In fact, 
those same studies helped illustrate the close association between the nuclear 
matrix and intermediate filaments (198,199). 
 Overall, we hypothesized that CSK and RSB buffers, when used 
sequentially, would solubilize G-actin and F-actin separately. Tubulin and 
intermediate filament proteins would serve as control markers for CSK and RSB 
fractions, respectively. The general approach for this procedure is visually 
described in Figure 3.1. The proceeding is a series of experiments looking into 
the use of CSK/RSB as a novel method for actin fractionation. This system was 
tested against pharmacological modulators of actin in fibroblastic, adherent cells 
with great success. CSK/RSB fractionation is a simple method that allows for 
normalization of the actin levels for a more accurate description of actin 
dynamics. 
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Figure 3.1 CSK/RSB fractionation method 
The CSK/RSB fraction method for the isolation of G-actin and F-actin involves to major steps. 
First, adherent cells are incubated in cold CSK for a few minutes.CSK is gently removed from the 
plate and reserved. Under these conditions, CSK should now contain G-actin and depolymerized 
microtubules. Second, an equal volume of RSB is added to the cells. After a short incubation, 
RSB can be gently reserved or used to scrape the adherent cell monolayer. Either approach will 
extract F-actin and intermediare filament.  
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Results 
Short CSK/RSB incubations extract detectable amounts of actin 
 We wanted to first gauge the feasibility of detecting actin after only brief 
CSK incubation. Data from the literature suggest that CSK incubations can, 
within the span of minutes, solubilize cytoplasmic proteins. Ornelles and  
colleagues extracted cytoplasmic proteins from adherent cells after just 3 
minutes of incubation (195). Gilbert and colleagues measured protein loss 
associated with incubation in a Triton-based buffer and found protein loss plateau 
at the 5 minute mark for CCL-146 cells, a gerbil-derived fibroblast (200). With 
these time frames in mind, we incubated cells in CSK buffer for 2, 4 or 10 
minutes. All CSK incubations were followed with scraping of the remaining cell 
monolayer in an equal volume of RSB. Actin was detected at all three incubation 
times, with minimal variability in CSK and RSB fraction enrichment with time 
(Figure 3.2). Cyclophilin A, named after its association with the 
immunosuppressive drug cyclosporin A, is known to be steadily expressed by 
fibroblastic cells including 3T3-L1 cells (201). This ubiquitous intracellular protein 
was detected in the CSK fraction following incubation at all time points. The 
intermediate filament protein vimentin was detected in the RSB fraction at all time 
points as well. Vimentin is the most widely distributed of intermediate filament 
proteins and is known to be expressed by fibroblasts (191). The data confirms 
that actin, along with cytoplasmic proteins are extracted by CSK incubation within  
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Figure 3.2 Short CSK incubations extract actin  
Western blot analysis of fractions collected from 3T3-L1 cells incubated in CSK for the desginated 
amount of time then scraped in RSB. Both the fractionation and the gel loading were conducted 
under equal volumes. Approximately 10% of fraction volume was loaded per lane.  
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minutes. CSK incubation does not solubilize a subset of proteins including 
vimentin.   
CSK extracts cytoplasmic G-actin without disrupting the F-actin network of 
10T1/2 cells 
 Although the literature indicates that CSK is only stringent enough to 
solubilize cytoplasmic proteins, we were not certain as to whether CSK 
incubation would selectively isolates cytoplasmic G-actin and not F-actin. 
To determine the specificity of CSK, we immunostained C3H10T1/2 
mesenchymal (10T1/2) cells, for F-actin and G-actin following incubation in either 
PBS or CSK (Figure 3.3). F-actin was found across the cell in a vast network 
after both PBS and CSK incubation (Figure 3.3a). G-actin staining after CSK 
incubation to suggest G-actin was much lower than after PBS (Figure 3.3a). 
Interestingly, G-actin colocalized with the nucleus in cells whether they were 
incubated with CSK or PBS.  
 In the literature, F-actin and G-actin enrichment is analyzed as a ratio, F-
actin/G-actin. We conducted a similar analysis based on the fluorescence 
intensity of these immunostained 10T1/2 cells (Figure 3.3b).We found that F-
actin/G-actin significantly increased as a result of CSK incubation. Increases in 
F-actin/G-actin indicate a decrease in G-actin, an increase in F-actin or a 
combination therein. To determine which accounted for the observed increase F-
actin/G-actin, we took the same data set and analyzed F-actin and G-actin  
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Figure 3.3 CSK extracts cytoplasmic G-actin without disrupting the F-actin network of 
10T1/2 cells 
(A) 10T1/2 cells were incubated in cold PBS or cold CSK for 10 minutes on ice and fixed for 
immunostaining. Cells were incubated with fluorescently-tagged phalloidin (F-actin) and DNase 
(G-actin) and counterstained with DAPI (Nucleus). Images were taken at 20x magnification. 
(B) Relative fold change in F-actin/G-actin under PBS incubation and under CSK incubation. 
Quantified total fluorescence from the red channel (G-actin) was normalized to the quantified total 
fluorescence from the green channel (F-actin). Graphs show fold change ± SEM (n=4); * p≤0.05. 
(C) Fold change in F-actin and in G-actin after CSK incubation relative to PBS. Quantified total 
fluorescence from the green channel (F-actin) and from the red channel (G-actin) was normalized 
against total blue channel fluorescence (Nucleus) to account for cell number variation. Graphs 
show fold change ± SEM (n=4); ** p≤0.005, *** p≤0.0005.   
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separately as a function of incubation (Figure 3.3c). This analysis revealed that 
the G-actin pool experienced a greater loss than the the F-actin pool following  
CSK incubation. A loss in G-actin, therefore, accounts for the increased F- 
actin/G-actin. We can conclude that CSK indeed targets cytoplasmic G-actin, 
with mild effects on the F-actin network and no effect on overall cell morphology. 
CSK extracts cytoplasmic G-actin without disrupting the F-actin network of 
3T3-L1 cells 
 To determine whether cytoplasmic G-actin is solubilized by CSK in other 
cell lines, we recapitulated the experiments from Figure 3.3 in 3T3-L1 cells 
(Figure 3.4). As with 10T1/2 cells, CSK incubation had a negligible effect on F-
actin distribution and cell morphology (Figure 3.4a). Although significant loss in 
G-actin staining was observed, a subset was found to again co-localize with the 
nucleus following CSK incubation. When we analyzed F-actin/G-actin we found a 
small yet significant increase in F-actin/G-actin (Figure 3.4b). When the  
data were re-analyzed, we found that the increase in F-actin/G-actin was largely 
the result of cytoplasmic G-actin loss (Figure 3.4c). We concluded that CSK 
selectively solubilizes cytoplasmic G-actin in 3T3-L1 cells as well. 
CSK and RSB buffers efficiently solubilize cytoskeletal proteins 
  With the specificity of CSK for cytoplasmic G-actin established, we sought 
to determine how efficient CSK and RSB incubations are at solubilizing target 
proteins. To test CSK/RSB efficiency, we performed a sequence of CSK and  
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Figure 3.4 CSK extracts cytoplasmic G-actin without disrupting the F-actin network of 3T3-
L1 cells 
(A) 3T3-L1 cells were incubated in cold PBS or cold CSK on ice for 10 minutes and fixed for 
immunostaining. Cells were incubated with fluorescently-tagged phalloidin (F-actin) and DNase 
(G-actin) and counterstained with DAPI (Nucleus). Images were taken at 20x magnification. 
(B) Relative fold change in F-actin/G-actin under PBS incubation and under CSK incubation. 
Quantified total fluorescence from the red channel (G-actin) was normalized to the quantified total 
fluorescence from the green channel (F-actin). Graphs show fold change ± SEM (n=3); * p≤0.05. 
(C) Fold change in F-actin and in G-actin after CSK incubation relative to PBS. Quantified total 
fluorescence from the green channel (F-actin) and from the red channel (G-actin) was normalized 
against total blue channel fluorescence (Nucleus) to account for cell number variation. Graphs 
show fold change ± SEM (n=3). 
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RSB incubations described in Figure 3.5a. We hypothesized that one round of 
CSK incubation (CSK1) would be sufficient to isolate all soluble, cytoplasmic 
proteins including, but not limited to, G-actin and tubulin, specifically α-tubulin. 
This isoform of tubulin is found in a dimeric complex with β-tubulin when 
microtubules are depolymerized (191). One round of CSK incubation solubilized 
61% of total β-actin protein with a second round isolating only an additional 4% 
(Figure 3.5b and 3.5d). Both α-tubulin and cyclophilin A were detected in CSK1 
and not CSK2 to confirm CSK efficiently solubilized cytoplasmic proteins.  
 RSB was designed to solubilize otherwise insoluble protein which we 
hypothesized would include F-actin and intermediate filament proteins. RSB 
incubation isolated vimentin and a subset of actin not solubilized by two rounds 
of CSK incubation (Figure 3.5b). The actin isolated by RSB1 represented 31% of 
total β-actin detected (Figure 3.5d). A second incubation with RSB isolated a 
negligible amount of vimentin and not actin. The data suggests RSB both 
specifically and efficiently solubilizes insoluble cellular protein including a subset 
of actin.  
 To confirm that the actin solubilized by RSB was F-actin, we also treated 
cells with swinholide A during the CSK/RSB series. Swinholide A is a marine 
toxin known to sever F- actin and stabilize actin dimers as a means of inhibiting 
polymerization (202). Swinholide A treatment did not alter total actin protein 
levels (Figure 3.5c). Instead, it caused the enrichment of β-actin in RSB1to  
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Figure 3.5 CSK and RSB buffers efficiently solubilize cytoskeletal proteins 
(A) A scheme describing the experiment conducted 
(B) Western blot analysis of sequential CSK and RSB fractions obtained from 3T3-L1 cells 
treated with DMSO or 0.1 μM swinholide A for 2 hours. 
(C) Western blot analysis of total protein obtained from 3T3-L1 cells treated with DMSO or 0.1 μM 
swinholide A for 2 hours. 
(D) Graph showing the relative distribution of β-actin protein levels detected across sequential 
CSK/RSB incubations of 3T3-L1 cells. Bars represent the percent distribution across fractions for 
DMSO and 0.1 μM swinholide A treatments, ± SEM (n=2).  
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decrease 17% and increased β-actin enrichment of CSK1 by 13% (Figure 3.5 b 
and 3.5d). Overall, we can conclude that both CSK and RSB efficiently at 
solubilize G-actin and F-actin, respectively. Actin was the only cytoskeletal 
protein solubilized by both CSK and RSB whereas tubulin was only solubilized by 
CSK and vimentin by RSB (Figure 3.5b). The data also illustrates that tubulin can 
be used as a marker for CSK extraction and vimentin as a marker for RSB. 
CSK/RSB fractionation discerns actin dynamics across cell types  
 We wanted to determine the versatility of these buffers as a fractionation 
method where we incubate the cells once in CSK buffer and then harvest the 
remaining cell layer in RSB buffer, a process we refer to as CSK/RSB 
fractionation. We performed CSK/RSB fractionation on 3T3-L1 cells (Figure 
3.6a), 10T1/2 cells (Figure 3.6b) and epididymal adipose-derived SVCs (Figure 
3.6c). We treated the cells with swniholide A, jasplakinolide or their  
vehicle, DMSO (Figure 3.6). Jasplakinolide is a cyclo-depsipeptide isolated from  
the marine sponge that binds and stabilizes F-actin (203,204).  
 We identified both similarities and differences by cell type following 
CSK/RSB fractionation. For all cell types, vimentin was isolated by RSB buffer 
while cyclophilin A and/or α-tubulin were isolated by CSK buffer. The enrichment 
of cyclophilin A in CSK matched the enrichment of cyclophilin A in total protein 
lanes to suggest that CSK solubilizes all cyclophilin A. Vimentin, on the other 
hand, displayed variable enrichment between RSB and total. In SVC and 10T1/2 
cells, vimentin is more enriched in total relative to RSB; 3T3-L1 showed the  
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  B. 
 
  C. 
 
Figure 3.6 CSK/RSB fractionation discerns actin dynamics  
Western blot analysis of total protein and CSK/RSB fractions isolated from sets of 3T3-L1 cells 
(A), C3H10T1/2 cells (B) and epiWAT SVC (C) treated with DMSO, 0.1 μM swinholide A and 0.5 
μM jasplakinolide for 30-45 minutes, equal volume loaded per lane.  
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opposite. The data suggest that some vimentin may be lost during CSK/RSB 
fractionation.  
 We probed most of the fractions for two actin isoforms, α-SMA and β- 
actin. In SVC and 3T3-L1 cells, α-SMA was enriched in the RSB fraction under 
vehicle conditions (Figure 3.6a and 3.6c). In 10T1/2 cells, both α-SMA and β-
actin were evenly distributed between CSK and RSB under vehicle conditions 
(Figure 3.6b). In SVC, both isoforms showed significant enrichment in the RSB 
fraction (Figure 3.6c). The α-SMA isolated from 3T3-L1 cells was enriched in the 
RSB fraction (Figure 3.6a). Swinholide A treatment caused a discernable shift in 
enrichment from RSB to CSK for the α-SMA in 3T3-L1 cells and the β-actin in 
SVC. Neither swinholide A nor jasplakinolide caused significant changes in 
10T1/2 cells under the conditions tested (Figure 3.6b). Overall, CSK/RSB 
fractionation can discern soluble and insoluble proteins in at least three types of 
cells. It also has the potential to trace both actin polymerization and 
depolymerization.  
Actin depolymerization can be quantified and normalized under CSK/RSB 
fractionation 
 We hypothesized that CSK/RSB fractionation would allow for an accurate 
quantification of actin dynamics because the fractionation allows for the 
identification of additional markers that can serve as normalizing controls. Based 
upon its consistent presence in total and CSK fractions, cyclophilin A was chosen 
a normalizing control for CSK. RNA polymerase II was chosen as a normalizing 
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control for RSB for similar reasons. To test our hypothesis, we treated cells with 
latrunculin A, a Red Sea Sponge-derived drug that binds G-actin to provoke actin 
depolymerization (205). Latrunculin A depolymerization was sufficient to reduce 
α-SMA and γ-actin enrichment in the RSB and augment them in the CSK fraction 
of SVCs (Figure 3.7a). Similar results were obtained in 3T3-L1 cells (Figure 
3.7b).  
 We quantified the depolymerization of actin by latrunculin A in 3T3-L1 
cells with and without normalizing the data (Figure 3.7c and 3.7d). Regardless of 
normalization, the baseline difference in β-actin enrichment between CSK and 
RSB was found to be statistically significant.  The increase in CSK enrichment as 
a result of latrunculin A was 3.9-fold while the decrease in RSB was 5.8-fold.  
When normalized against cyclophilin A, CSK enrichment increased 4.8-fold. 
When normalized against RNA polymerase II, RSB enrichment decreased 6.0-
fold. Normalization of the data, overall, brought the magnitudes of CSK and RSB 
change closer. It also made the increase in CSK statistically significant. 
 Interestingly, CSK enrichment of α-SMA did not quantifiably change as a 
result of latrunculin A treatment. Given the error bars associated with the α-SMA 
CSK values, we hypothesize that α-SMA does in fact signficantly change CSK 
enrichment following latrunculin. Based on the dynamics of β-actin, we can 
conclude that CSK/RSB allows for the rigorous quantification of actin 
depolymerization.  
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C.     D. 
  
Figure 3.7 Actin depolymerization can be quantified and normalized under CSK/RSB 
fractionation 
(A,B) Western blot analyses of total protein and CSK/RSB fractions isolated from SVC (A) or 3T3-
L1 (B) treated with DMSO (-) or 2 uM latrunculin A (+) for 10 minutes, equal volume loaded per 
lane. 
(C,D) Graphs of the relative distribution of α-SMA and β-actin protein detected in the CSK/RSB 
fractions of 3T3-L1 cells treated with DMSO (-) or 2 uM latrunculin A (+) for 10 minutes. In one 
set, the data was not normalized (C). In the other (D), CSK data was normalized against 
cyclophilin A and RSB data was normalized against RNA polymerase, ± SEM (n=3); * p≤0.05, 
**p≤0.005. 
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Discussion 
 In order to study actin dynamics at the level of the isoform, we needed a 
method to separate G-actin from F-actin simply and reliably. To address this 
need, we adopted the use of buffers to selectively solubilize these distinct pools 
of actin.  Based on their detergent content, we hypothesized that the set of  
buffers known as CSK and RSB would effectively solubilize G-actin and F-actin, 
respectively.  
 Given the proposed use of CSK first in a sequence of incubations (Figure 
3.1), we were concerned that CSK would not discern G-actin from F-actin. 
Immunostaining confirmed the ability of CSK to solubilize G-actin without 
dismantling the F-actin network (Figures 3.3a and 3.4a). When measured, a loss 
in F-actin was identified did not sufficient decrease F-actin/G-actin below PBS 
levels which indicated that the magnitude of G-actin loss exceeded the loss of F-
actin (Figure 3.3b and 3.4b). Because F-actin can exist in numerous lengths, the 
solubilization of short actin filaments by CSK is well within the realm of possibility. 
The immunofluorescence images assured us, though, that the bulk of the stress 
fiber network comprised of long actin filaments was not solubilized by CSK and 
thus we concluded that CSK readily solubilizes G-actin and not F-actin stress 
fibers. 
 By incorporating Western blot analysis into the CSK/RSB protocol, two 
distinct compartments can be validated through the detection of tubulin and 
vimentin. We demonstrated the efficiency with which CSK and RSB isolated α-
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tubulin and vimentin, respectively, justifying the use of these proteins as fraction 
control markers (Figure 3.5b). We also observed non-cytoskeletal proteins 
solubilized by these buffers. CSK consistently solubilized cyclophilin A and RSB, 
consistently solubilized RNA polymerase II. Actin was the only protein we 
detected consistently in both CSK and RSB fractions. The ratios of actin 
CSK/RSB enrichment varied by actin isoform, actin-targeting treatments and also 
cell type (Figure 3.6). Given the consistency of the control markers, we 
hypothesize that the variability observed reflects genuine differences among the 
systems tested. We are currently characterizing these variations with both 
dosage and time curves. 
 Although we primarily relied upon actin depolymerization to prove the 
efficacy of CSK/RSB fractionation, we did detect actin polymerization using 
CSK/RSB (Figure 3.6). Jasplakinolide did not notably alter actin polymerization in 
10T1/2 cells or SVCs. It reduced actin enrichment in the CSK of 3T3-L1 cells, but 
it did not cause a discernable enrichment of actin in the RSB (Figure 3.6a). 
Fibroblasts are known to be enriched with stress fibers so it likely that CSK/RSB 
fractionation is not sensitive enough to detect additions to an already rich stress 
fiber network. Again, careful dosage and time curves with jasplakinolide will help 
address whether CSK/RSB can discern actin polymerization as well as it can 
discern actin depolymerization.  
 The ability to detect proteins beyond actin sets CSK/RSB fractionation 
apart from comparable approaches. Like any other protein, actin expression is 
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subject to change in response to stimuli. Comparable approaches offer no way to 
normalize for either the differences in actin protein content or variations in cell 
number. The ability to normalize actin protein to internal controls makes 
CSK/RSB fractionation a more reliable approach for biochemically assessing 
actin dynamics. Normalizing β-actin protein levels enhanced our analysis of 
latrunculin A treatment (Figure 3.7d). Overall, the data confirms that CSK/RSB 
fractionation is a rapid and reliable method for the assessment of actin dynamics 
in cultured cells. 
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 CHAPTER FOUR 
THE ROLE OF GELSOLIN IN ADIPOGENIC ACTIN REORGRANIZATION 
Abstract 
 During adipogenesis, the actin cytoskeleton converts from F-actin rich 
network to an intracellular meshwork largely localized by the plasma membrane. 
In general, actin reorganization is orchestrated by actin binding proteins. Little is 
known about the role of actin binding proteins during adipogenesis. We identified 
that the actin binding protein gelsolin is transiently induced by dexamethasone.  
The absence of gelsolin did not alter the induction of the master regulator of 
adipogenesis, PPARγ. Using CSK/RSB fractionation, we also discover that 
gelsolin is not required for the reduction of F-actin that occurs during early 
adipogenesis.  
Introduction 
 The morphology of the mature adipocyte is exquisitely unique. It is 
spherical with, typically, a unilocular lipid droplet constituting roughly 90% of the 
cell‟s volume. Morphology is dictated in part by the cytoskeleton, a meshwork of 
intermediate filaments, microtubules and microfilaments. This meshwork is very 
dynamics and is actively involved in the spatial organization of cell content, 
regulating cell shape and movement along with connecting the cell to its external 
environment (206). During adipogenesis, the cytoskeleton is known to change 
dramatically. 
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 The intermediate filament cytoskeleton of the 3T3-L1 cell is comprised of 
only vimentin. Vimentin organization begins with a wavy, fibrillar organization but 
later migrates to surround nascent lipid droplets in cage-like monolayers (207). 
Perturbation of vimentin intermediate filaments with nocodazole was shown to 
reduce the formation of lipid droplets (208). Vimentin has not been associated 
with any perturbations in adipose tissue, in fact, mice lacking vimentin develop 
and reproduce without an obvious phenotype (209).  
 During 3T3-L1 adipogenesis, the microtubule cytoskeleton converges to 
cage-like structures around nascent lipid droplets in early adipogenesis and are 
later found perinuclear (210). Synthesis of the monomeric unit of microtubules, 
tubulin, decreases during adipogenesis (182). While microtubule disruption with 
nocodazole is pro-adipogenic, it likely does so by promoting cell rounding. Cell 
shape has been shown to regulate adipogenesis by modulating Rho/ROCK and 
actin cytoskeletal tension (156).  
 Unlike the microtubule and intermediate filament networks, the 
microfilament network does not change to encompass lipid droplets. Instead, the 
actin cytoskeleton changes from a long, stress fiber organization to a series of 
shorter filaments found adjacent to the plasma membrane referred to as cortical 
actin (211). The dramatic changes that occur to the actin cytoskeleton during 
adipogenesis have long been observed. The mechanisms orchestrating these 
changes have not been clearly established and roles for actin-binding protein that 
modulate actin organization seem likely. We hypothesized that, through its F-
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actin severing activity, gelsolin plays an important role in the reorganization of 
actin required for adipogenesis. 
 Gelsolin is the flagship member of an actin-binding protein superfamily 
(212).  Gelsolin acquired its name from the unique effect it was found to have on 
rabbit lung macrophage cytoplasmic extracts. The extracts were shown to go 
through cycles of gelation and solation that could be manipulated with the 
calcium chelator EGTA.  An actin-binding protein was identified as the driver of 
the observed cycles and as such acquired the name “gel-sol-in”, readily severing 
F-actin in response to calcium levels (213). Most members of the gelsolin 
superfamily sever F-actin and include proteins such as CapG and adseverin. All 
members contain at least three gelsolin homology (GH) domains in their 
structures (214). The GH domain is similar in structure to the signature domain of 
the cofilin /actin depolymerizing factor (ADF) superfamily of F-actin severing 
proteins.  
 Gelsolin is a large actin-binding protein comprised of six GH domains 
(215). Its N-terminal region houses the capacity to sever F-actin. The actual 
binding to F-actin is performed by the second and third domains. When bound, 
gelsolin caps F-actin which stops polymerization and allows the first domain to 
disrupt actin-actin hydrophobic interactions leading to F-actin severance (215). 
Severance activity is regulated by the conformation of the C-terminal region 
which responds to changes in calcium, phosphatidylinositol phosphates and pH 
(212). F-actin severance can only occur when C-terminal region is in an open 
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conformation, exposing the N-terminal region.  An open conformation is achieved 
under calcium concentrations high enough for the C-terminal region to bind. A 
closed conformation occurs in the presence of phosphatidylinositol phosphates, 
in particular PIP2, and/or >6.5 pH which causes gelsolin to dissociate from F-
actin and promote actin polymerization (216). 
 The gelsolin gene is expressed as two variants, a secreted, plasma 
variant and a cytoplasmic variant. The gelsolin originally described by Helen Yin 
and colleagues is the cytoplasmic variant. A plasma protein previously known as 
brevin was found to share identity with gelsolin and was renamed plasma 
gelsolin (217). Plasma gelsolin has an additional 25 amino acid residues at its N-
terminus and is thought to be produced largely by muscle cells (218). Like 
cytoplasmic gelsolin, plasma gelsolin can sever F-actin. It is thought to play an 
important role in the clearance of actin released during cell death (215). 
Interestingly, plasma gelsolin mutation has been tied to a rare hereditary amyloid 
polyneuropathy (219).  
 The absence of gelsolin has major physiological effects. In mice, gelsolin 
expression is first detected at E11.5. In the mature mouse, it is predominately 
expressed in the heart and lungs and is otherwise considered to be ubiquitously 
expressed (220). Gelsolin deletion in BALB/c and C57/bl mouse backgrounds 
causes lethality at E17 and postnatal day 12, respectively (216). In mice not of 
the BALB/c and C57/bl backgrounds, the absence of gelsolin does not alter 
longevity. These gelsolin deficient mice instead experience notable defects in 
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hemostatic response, fibroblast function and platelet activation. Their platelets 
contain more actin filaments and cannot effectively spread upon activation, a 
response that is critical in wound healing (221). Dermal fibroblast size is five-fold 
larger due to stress fiber formation which impacts cell motility. Without gelsolin, 
osteoclasts cannot assemble podosomes well, which inhibits bone remodeling 
(222).  
 The expression and relevance of gelsolin in adipose tissue has not been 
investigated. Published microarray data available on GeoDatasets indicate an 
enrichment of gelsolin in murine WAT as compared to BAT and in mature white 
and brown adipocytes as compared to their primary progenitor cells (32,223). 
Gelsolin has been studied in 3T3-L1 cells by Kawaji and colleagues (224). They 
found that in the absence of gelsolin, 3T3-L1 adipocytes expressed less C/EBPα 
and PPARγ transcript and accumulated fewer lipid droplets. The authors 
concluded that gelsolin is required for adipogenesis and likely plays a role in 
mitotic clonal expansion. Interestingly, gelsolin‟s role in mitotic clonal expansion 
or adipogenesis overall were not connected back to gelsolin‟s F-actin severing 
capacity.  
 Overall, the literature on gelsolin identifies its F-actin severing capacity to 
play an important role in its physiological relevance.  In this chapter, we set out to 
determine whether gelsolin is indeed expressed by adipocytes and to better 
characterize its role within adipose tissue. We explore the possibility that gelsolin 
 
 
 
65 
is required during adipogenesis for the reorganization of F-actin stress fibers in 
3T3-L1 cells.  
Results 
Gelsolin is expressed by white adipocytes 
 To determine the biological relevance of gelsolin in context of 
adipogenesis, we first examined whether gelsolin is expressed by adipose tissue. 
Gene expression was analyzed in depots that represent white, brite/beige and 
brown adipose tissue, respectively:  epididymal white adipose tissue (epiWAT), 
inguinal adipose tissue (ingWAT) and intrascapular brown adipose tissue (iBAT) 
(Figure 4.1). The epididymal adipose depot is visceral, located next to the 
epididymis. The inguinal adipose depot (ingWAT) is subcutaneous, running along 
the hindlimb and, although considered a white adipose depot, expresses a 
subset of brite/beige adipose markers. The intrascapular brown adipose depot is 
found as two lobes between the shoulder blades.  
 RNA isolated from the adipose tissue of 6 week old mice was analyzed for 
gelsolin gene expression by qPCR, as shown in Figure 4.1a. Gene expression of 
the adipocyte marker PPARγ is comparable across adipose depots. As expected, 
adiponectin gene expression was enriched in the epiWAT and ingWAT. CideA, a 
gene that is predominately expressed in brown fat, is significantly enriched in 
BAT (225). These markers collectively confirmed the white and brown identities 
of the depots isolated. Like adiponectin, gelsolin gene expression was enriched  
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Figure 4.1 Gelsolin is expressed by white adipocytes 
 (A) Relative mRNA levels of select genes in the epiWAT, ingWAT and iBAT of 6 week old mice 
as analyzed by qPCR. Graphs show fold difference ± SEM (n=3); * p≤0.05, ** p≤0.005.  
(B) Relative mRNA levels of select genes in the adipocyte fraction (AF) and stromal vascular 
fraction (SVF) isolated from the epiWAT of 7 week old mice as analyzed by qPCR. Graphs show 
fold difference ± SEM (n=3); * p≤0.05.  
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in white adipose with a trending enrichment in epiWAT over ingWAT. There is 
significantly less gelsolin gene expression in iBAT.  
  Because adipose tissue is comprised of both adipocyte and non-
adipocyte cells, we wanted to determine which subset expresses gelsolin. Whole 
epiWAT from 7 week old mice was digested into their respective adipocyte (AF) 
and stromal vascular fractions (SVF) and analyzed by qPCR (Figure 4.1b). As 
anticipated, PPARγ gene expression was enriched in the AF and the 
preadipocyte marker Pref1 in the SVF. Gelsolin was detected in both fractions  
suggesting it is ubiquitous. The data collectively suggests that gelsolin is 
expressed by adipose tissue, in particular WAT.  
Gelsolin is transiently induced during early adipogenesis 
 To determine when adipocytes acquire gelsolin expression, we measured 
gelsolin expression in 3T3-L1 cells (Figure 4.2). Western blot analysis of gelsolin 
protein revealed doublet bands detectable on Days 0 and 2 (Figure 4.2a). The 
higher molecular weight band is likely the secreted gelsolin isoform, although this 
has not yet been confirmed with recombinant protein. The lower molecular weight 
band, gelsolin, was expressed at every time point examined. At the transcript 
level, there was no significant difference in gelsolin expression between Day 0 
and Day 10 despite a slight drop in gelsolin protein on Day 10 (Figure 4.2). 
Gelsolin expression both at the protein (Figure 4.2a) and transcript (Figure 4.2b) 
level revealed transient induction on Day 2. No similar  
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Figure 4.2 Gelsolin is transiently induced during early adipogenesis 
 (A) Western blot analysis of total cellular protein extracted from Day 2 3T3-L1 cells treated with 
the labeled combination(s) of adipogenic cocktail for 48 hours.  
(B) Relative mRNA levels of gelsolin from Day 2 3T3-L1 cells treated with the labeled 
combination(s) of adipogenic cocktail for 48 hours as analyzed by qPCR. Graphs show fold 
difference ± SEM (n=3); * p≤0.05,  ** p≤0.005, ***p≤0.0005  
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induction of the F-actin severing protein cofilin or of destrin, also known as actin 
depolymerizing factor (ADF), was observed (Figure 4.2b).   
Dexamethasone induces gelsolin during hormonal induction  
 The transient induction of gelsolin on Day 2 coincides with the period of 
hormonal induction. Interestingly, a component of the adipogenic cocktail, 
dexmethasone, has been shown to induce gelsolin in L929 cells (226). In those 
cells, gelsolin induction also corresponded with diminished F-actin content and 
changes in L929 morphology. We hypothesized that gelsolin‟s transient induction 
was a direct result of the dexamethasone in the adipogenic cocktail. 
Dexamethasone is a synthetic glucocorticoid receptor ligand that has been 
shown to induce the expression of glucocorticoid-induced leucine zipper (GILZ) 
(227).  We found that dexamethasone significantly induced GILZ protein (Figure 
3A) and transcript (Figure 4.3). Gelsolin protein (Figure 4.3a) and transcript 
(Figure 4.3b) levels were also induced by the inclusion of dexamethasone in the 
adipogenic cocktail.  
Gelsolin induction is largely regulated by glucocorticoid receptor  
 Since dexamethasone induced both GILZ and gelsolin during 3T3-L1 
hormonal induction, we hypothesized that glucocorticoid receptor activity was 
responsible for the observed induction of gelsolin as it is for GILZ. To test this, 
we closely examined the contributions of both dexamethasone and glucocorticoid 
receptor to the observed gelsolin induction. First, we modified the adipogenic   
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Figure 4.3 Dexamethasone induces gelsolin during hormonal induction 
(A) Western blot analysis of total cellular protein extracted from Day 2 3T3-L1 cells treated with 
the labeled combination(s) of adipogenic cocktail for 48 hours.  
(B) Relative mRNA levels of gelsolin in Day 2 3T3-L1 cells treated with the labeled combination(s) 
of adipogenic cocktail for 48 hours as analyzed by RT-PCR. Graphs show fold difference ± SEM 
(n=3); * p≤0.05, ** p≤0.005, ***p≤0.0005  
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Figure 4.4 Gelsolin induction is largely regulated by dexamethasone and glucocorticoid 
receptor 
(A) Western blot analysis of total cellular protein extracted from Day 2 3T3-L1 cells treated with 
increasing concentrations of dexamethasone within the adipogenic cocktail for 48 hours.  
(B) Relative mRNA levels of gelsolin in Day 2 3T3-L1 cells treated with increasing concentrations 
of dexamethasone within the adipogenic cocktail for 48 hours. Graphs show fold difference ± 
SEM (n=3); * p≤0.05, ***p≤0.0005.  
(C) Relative mRNA levels of gelsolin in Day 2 3T3-L1 cells stably expressing glucocorticoid 
receptor (GR) shRNA as compared to control (Ctrl) shRNA. Graphs show fold difference ± SEM 
(n=4); * p≤0.05, ***p≤0.0005.   
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cocktail to contain IBMX, insulin and a range of dexamethasone concentrations 
(Figure 4.4). The complete omission of adipogenic cocktail (no MI) and the  
omission of dexmethasone from the cocktail (MI+ethanol) were included as 
controls.  
 GILZ protein (Figure 4.4a) experienced a linear, dose-dependent increase 
in response to dexamethasone through the maximal dose of 20 μM (Figure 4.4a). 
GILZ transcript levels rose 20 fold under 0.5 μM dexamethasone and showed no 
dose dependence (Figure 4.4b). As a negative control for the effect of 
dexamethasone, we also measured the effect it had on Pref1 transcript level. 
Dexamethasone has been shown to repress the transcription of Pref1 in 3T3-L1 
cells (228). We found that all doses of dexamethasone tested downregulated 
Pref1 equally (Figure 4.4b). 
 Gelsolin protein was again induced by dexamethasone but not in a dose-
dependent pattern. Instead, gelsolin protein was significantly induced under 
cocktail containing 0.5 μM dexamethasone, a dose that is half the concentration 
normally used in adipogenic cocktail (Figure 4.4a). Treatment with I μM 
dexamethasone in the adipogenic cocktail achieved a similar level of gelsolin 
protein induction. Under 10 μM and 20 μM dexamethasone in the adipogenic 
cocktail, gelsolin protein levels were equal to the level seen under the exclusion 
of dexamethasone in the adipogenic cocktail (Figure 4.4a). At the transcript level, 
dexamethasone concentrations ranging from 0.5 μM to 10 μM in the adipogenic 
cocktail achieved significant yet equal gelsolin induction. Gelsolin was also  
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induced by cocktail containing 20 μM dexamethasone, but the induction was less 
than those experienced under lower dexamethasone concentrations in the 
adipogenic cocktail (Figure 4.4b). The data confirm that dexamethasone induces 
the expression of both GILZ and gelsolin, albeit with distinct dose dependencies.
 With a role for dexamethasone confirmed, we next tested the role of 
glucocorticoid receptor in the transient induction of gelsolin. We differentiated 
3T3-L1 cells expressing shRNA targeting glucocorticoid receptor gene 
expression and compared the results to 3T3-L1 cells expressing a control shRNA 
construct. The cell lines were analyzed on Day 2 where shRNA achieved a 
significant knockdown of glucocorticoid receptor gene expression, roughly 70% 
(Figure 4.4c). Because glucocorticoid receptor activity enhances adipogenesis, 
its knock down significantly reduced PPARγ transcript levels (229). As 
hypothesized, gelsolin transcript levels were was significantly reduced in the 
absence of glucocorticoid receptor as were the transcript levels for the known 
target gene GILZ (Figure 4.4c). Collectively, the data confirms that transient 
induction of gelsolin during 3T3-L1 differentiation is dependent upon 
dexamethasone-driven glucocorticoid receptor activity since the absence of 
either dexamethasone or glucocorticoid receptor blunts gelsolin induction. 
Gelsolin co-localizes with F-actin during early adipogenesis 
 It is well established that F-actin stress fibers are lost and cortical actin is 
gained during adipogenesis. What distinguishes these two networks is the 
density and length of F-actin. Stress fibers are long actin polymers that can span 
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the length of a cell. Stress fibers must be shortened and spatially relocated to 
become the cortical actin signature to the mature adipocytes. Given gelsolin‟s 
known F-actin severing activity and its induction during early adipogenesis, we 
hypothesized that gelsolin induction coincides with a loss in F-actin. We 
examined the relationship between gelsolin‟s presence on Day 2 and the loss of 
F-actin by conducting an immunofluorescence time course (Figure 4.5).   
 Significant amounts of F-actin were lost between Day 0 and Day 2 as 
indicated by the diminished intensity of phalloidin-associated staining (Figure 4.5, 
top left panels). On both Day 0 and Day 2, gelsolin was found to strongly 
colocalize with F-actin (Figure 4.5, top right panels). By Day 8, both F-actin and 
gelsolin were largely absent relative to Day 0. The data shows that gelsolin 
associates with F-actin during early adipogenesis.   
Gelsolin is not required for adipogenic actin reorganization 
 To determine whether the loss of F-actin observed in Figure 4.5 is a result 
of F-actin severing by gelsolin, we knocked down gelsolin expression with siRNA 
and observed the impact on both actin dynamics and adipogenic potential 
(Figure 4.6). Gelsolin-specific siRNA significantly downregulated gelsolin 
transcript levels at all concentrations tested (Figure 4.6a). The 10 nM siRNA 
concentration achieved the greatest difference in gelsolin transcript levels and, 
as such, was used in all subsequent gelsolin knock down experiments. Gelsolin 
protein levels were also significantly downregulated by 10 nM gelsolin siRNA  
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Figure 4.5 Gelsolin co-localizes with F-actin during early adipogenesis 
Immunofluorescence time course study of 3T3-L1 cells. Cells were stained with ActiStain-488 
phalloidin, incubated in gelsolin antibody (Gelsolin), and counterstained with DAPI (Nuclei) two 
days post-confluence (Day 0), two days into adipogenic cocktail treatment (Day 2) and six days 
after removal of the adipogenic cocktail (Day 8). Images were taken at 20x magnification. 
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Figure 4.6 Gelsolin is not required for adipogenic actin reorganization 
(A) Relative mRNA levels of gelsolin in 3T3-L1 cells following transfection with 1 nM, 10 nM or 30 
nM control or gelsolin. Graphs show fold difference ± SEM (n=4); ** p≤0.005, ***p≤0.0005. 
(B) Western blot analysis of total protein extracted from Day 2 3T3-L1‟s transfected with 10 nM 
gelsolin or control siRNA and treated with variations of the adipogenic cocktail. Gels were loaded 
with 25 ug protein per lane.  
(C) Western blot analysis of Day 2 3T3-L1‟s transfected with 10 nM gelsolin or 10 nM control 
siRNA. Cells were incubated in CSK buffer for 10 minutes then scraped with an equal volume of 
RSB buffer. Fractions were loaded equal volume per lane. 
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transfection (Figure 4.6b and 4.6c). Interestingly, gelsolin protein isolated by the 
CSK/RSB fractionation method was detected in the CSK fraction which is in 
agreement with the fact that gelsolin is a cytoplasmic protein that non-covalently 
interacts with F-actin (Figure 4.6b). 
 To describe the polymerized state of actin in the absence of gelsolin, we 
performed CSK/RSB fractionations on gelsolin siRNA transfected, Day 2 3T3-L1 
cells (Figure 4.6b). We hypothesized that the absence of gelsolin would allow for 
more F-actin in the cell, detected as an enrichment of actin in the RSB fraction. 
Under adipogenic cocktail vehicle, the absence of gelsolin did not cause an 
enrichment of actin isoforms in the RSB fraction (Figure 4.6b). As expected, 
adipogenic cocktail reduced αSMA protein levels significantly and β-actin protein 
levels minimally; actin was also reduced in both CSK and RSB fractions. The 
loss of actin in both CSK and RSB fractions was no different between control and 
gelsolin siRNA transfected cells (Figure 4.6b). Based on the data, we can 
conclude that gelsolin is not required for the observed loss of F-actin during 
adipogenesis.  
 The literature suggests gelsolin is required for adipogenesis (224,230). 
When we examined PPARγ expression in Day 2 3T3-L1 cells, we found no 
difference in PPARγ protein levels in the absence of gelsolin (Figure 4.6c). Our 
data suggest that, in fact, gelsolin is not required for adipogenesis.  
 
 
 
78 
Discussion 
 Based on the actin severing abilities of gelsolin and its known expression 
in 3T3-L1 cells, we wanted to determine whether gelsolin contributed to 
adipogenic actin reorganization. Before examining gelsolin more closely in the 
3T3-L1 cells, we first wanted to determine whether gelsolin could be biologically 
relevant in adipose tissue. RNA analysis revealed that gelsolin is in fact 
expressed by adipose tissue and is likely, particularly WAT (Figure 4.1a). 
Adipose tissue had not been previously examined for gelsolin expression relative 
to other tissues and organs. We did not conducted measurements in non-
adipose tissues but it would be interesting to see how gelsolin expression 
adipose tissue compares to tissues known to be enriched with gelsolin, namely 
the heart and lungs. 
 We found gelsolin did not experience significant net changes in 
expression from the preadipocyte stage to the adipocyte stage (Figure 4.2). 
Instead, gelsolin was observed to transiently induce concomitantly with hormonal 
induction. We went on to identify dexamethasone as the key trigger behind 
gelsolin transient induction (Figure 4.3). To confirm this, we examined the 
contributions of dexamethasone‟s target, glucocorticoid receptor. In the absence 
of glucocorticoid receptor, hormonal induction no longer induced gelsolin (Figure 
4.4c). The transient induction of gelsolin during adipogenesis adds to the growing 
list of glucocorticoid receptor functions. 
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 We hypothesized that major role for lied in its actin severing ability. Based 
on our CSK/RSB fractionation results, we concluded that no such role existed 
(Figure 4.6b). With so many actin binding proteins regulating the organization of 
the actin cytoskeleton, gelsolin is unlikely to be solely responsible for adipogenic 
actin dynamics. Although we ultimately found no role for gelsolin in adipogenic 
actin reorganization, we showed that dexamethasone/glucocorticoid receptor 
regulate a transient induction of gelsolin during 3T3-L1 adipogenesis. This may 
help further insight into the role(s) for gelsolin in adipogenesis. 
 Despite its induction by dexamethasone, we found that gelsolin is likely 
not required for adipogenesis. Kawaji and colleagues used shRNA to knockdown 
gelsolin roughly 70% in 3T3-L1 cells (224). They found decreased lipid content 
and PPARγ, Ap2 and C/EBPα transcript levels to suggest  gelsolin is required for 
adipogenesis. With siRNA, we knocked down gelsolin >70% (Figure 4.6) yet no 
significant change in PPARγ protein levels were observed (Figure 4.6b and 4.6c) 
prompting us to conclude that gelsolin is not required for adipogenesis. Gelsolin 
could still play important adipogenic roles, though. The Kawaji study provided 
convincing data to suggest gelsolin plays an important role in mitotic clonal 
expansion (MCE). Glucocorticoids are required for MCE and we showed that 
glucocorticoids also induce gelsolin expression during the period of time 
coinciding with MCE (Figure 4.4) (229), supporting the theory of a role for 
gelsolin in MCE. 
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 Gelsolin aside, this set of studies revealed interesting information on the 
nature of actin dynamics. Typically, the depolymerization of F-actin generates G-
actin. We observed a decrease in F-actin following hormonal induction that was 
not accompanied by an increase in G-actin (Figure 4.6b). This is likely not an 
isoform specific phenomenon since α-SMA and β-actin were equally affected. 
Although the spatial organization of actin is regulated by actin binding proteins, it 
is also regulated by the abundance of actin itself. With this in mind, we studied 
the expression and distribution of actin isoforms to identify regulatory 
mechanisms beyond actin binding proteins.  
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CHAPTER FIVE 
THE ISOFORM-SPECIFIC DYNAMICS OF ACTIN DURING EARLY 
ADIPOGENESIS 
Abstract 
 It is well known that the actin cytoskeleton is downregulated and 
reorganized during the course of adipogenesis. These events are important for 
the progression of adipogenesis, but actin itself has largely been studied as a 
single protein when in fact it exists as a gene family. In this study, we assessed 
the dynamics and expression of each actin isoform during adipogenesis. We 
found that the α-SMA isoform experiences very dramatic changes. We also 
explore the mechanisms by which actin expression is downregulated, where we 
identify roles for both the transcriptional complex MRTF/SRF and the cAMP 
signaling pathway during the early stages of adipogenesis.  
Introduction 
 Three decades ago, actin protein levels were discovered to be 
dramatically downregulated during the course of 3T3 adipogenesis (231). In 
addition, actin protein biosynthesis decreases approximately 5-fold (232). These 
studies describing the downregulation of actin reflect a change in pan actin. The 
extent to which each isoform experiences these changes is currently unknown. 
Furthermore, the actin isoform profiles of preadipocyte and adipocytes is 
currently unknown.   
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 Actin isoform profiles can reveal much about the identity and function of a 
cell. For example, epithelial cells undergoing EMT experience changes in β-actin 
and γ-actin organization and an increase in smooth muscle actin expression as 
they acquire a fibroblast-like phenotype (233,234). Changes in actin 
reorganization, concomitant to the changes in actin expression, facilitate the 
migratory capacity acquired during EMT (235). In myofibroblasts, α-SMA can 
comprise 20% of the actin expressed yet even a mild increase in α-SMA 
expression is sufficient to augment stress fiber content and contractility 
(236,237). In the absence of α-SMA, though, myofibroblast phenotype is largely 
unaffected; other actin isoforms are augmented to yield no net change in total 
actin expression (238). These studies collectively demonstrate the complexity 
and importance of actin isoform expression and distribution.  
  In this study, we examine the adipogenic actin isoform cytoskeleton 
profile. Using our CSK/RSB fractionation method, we were able to track changes 
in actin expression and polymerization in parallel. This is significant considering 
that both parameters are known to change during adipogenesis yet the balance 
between them has not been analyzed, especially not at the isoform level. A 
general schematic timeline of the changes in actin during adipogenesis is 
depicted in Figure 5.1. Through these efforts, we characterized an interesting net 
loss of both G-actin and F-actin during early adipogenesis. We also identified the 
α-SMA isoform as one that is disproportionately downregulated and reorganized. 
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Figure 5.1 Actin changes as a function of adipogenesis 
During 3T3-L1 differentiation, the cells must first reach confluence (Day -2). Two days post-
confluence (Day 0), the cells are given an adipogenic cocktail for 48 hours. The cocktail is 
removed and within 24-48 hours lipid droplets begin to be visible. Actin biosynthesis is known to 
decrease although the starting point for this is unclear. The actin cytoskeleton is also reorganized 
from stress fiber rich network to a cortical network.  
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The MRTF/SRF transcriptional complex is a major regulator of actin 
cytoskeleton-specific genes. The 26 SRF-regulated actin cytoskeleton genes can 
be grouped into three categories by function: structural (e.g. actin), effectors of 
actin turnover (e.g. cofilin 1) and regulators of actin dynamics (e.g. Arp2/3, talin 
1) (178,239). Recent studies into the role of MRTF in adipocyte biology have 
identified it as a major contributor to lineage determination, in particular beige 
adipocyte determination (179,240). Its inactivation, facilitated in part by G-actin-
driven sequestration in the cytoplasm, is required for adipogenesis (180).  
 MRTF/SRF inactivation occurs during early adipogenesis and coincides 
with the loss in actin expression. Our studies identified a role for MRTF/SRF in 
the regulation of actin isoform expression, particularly of α-SMA. The early loss of 
α-SMA appears to be important for the progression of adipogenesis since a 
second round of actin attenuation, this time by cyclic AMP, occurs during 
hormonal induction. Hormonal induction also caused significant reductions in the 
expression of the cytoplasmic isoforms. Through these studies, we have 
established an adipogenic actin profile that will enhance our understanding of the 
mechanisms of adipogenic commitment that will ultimately enable us to better 
understand the expansion of adipose tissue and obesity. 
Results 
α-SMA is enriched in the stromal vasculature of white adipose tissue 
 We began our investigation of actin by first examining the expression 
levels of all relevant actin isoforms in adipose depots (Figure 5.2). We observed 
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1.8-fold of β-actin in epiWAT relative to iBAT. Enrichment of α-SMA in the WAT 
exceeded the enrichment by β-actin. It was found to be present 15-fold more in 
ingWAT and 26-fold more in epiWAT relative to iBAT (Figure 5.2b). Transcript 
levels of the cytoplasmic isoforms, coded as their gene names Actb and Actg1,  
show very similar patterns of expression as was observed at the protein level 
(Figure 5.2c). Although not statistically significant, β-actin and γ-actin trended 
towards enrichment in epiWAT. Transcript levels of α-SMA, coded as its gene 
name Acta2, showed 8-fold enrichment in epiWAT. The transcript pattern of α-
SMA was similar to that of adiponection (AdipoQ), an adipokine produced largely 
by WAT. As anticipated, the expression of the BAT-specific gene UCP-1 was 
detetced exclusively in iBAT (Figure 5.2c).  
 Adipose tissue is comprised of a milieu of cells and since actin is 
ubiquituous, the presence of actin is attributable to both adipocyte and non-
adipocytes. To parse the actin contribution of each, we measured actin 
isoform transcript levels in the adipocyte fraction (AF) and stromal vascular 
fraction (SVF) of epiWAT. Because actin synthesis is downregulated during 
adipogenesis, we hypothesized that actin expression would be limited to the 
SVF. Transcript level differences for α-SMA in AF and SVF were enough to 
suggest that α-SMA expression is largely isolated to the SV; repeating the 
experiment withmore mice will minimize error and reveal statistical significance 
(Figure 5.2d). Based upon these adipose tissue studies, we can conclude that  
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Figure 5.2 α-SMA is enriched in the stromal vasculature of white adipose tissue 
(A) Western blot analysis of whole adipose tissue harvested from four 6 week old, non-littermate 
mice. Total protein was isolated from intrascapular brown (iBAT), inguinal white (ingWAT) and 
epididymal white (WAT) adipose depots. Equal protein was loaded per lane. 
(B) Densiometric analysis of Western blot (A) with totals normalized to cyclophilin A. Graph 
shows fold difference ± SEM (n=4); * p≤0.05, ** p≤0.05. 
(C) Relative mRNA levels of select genes expressed by iBAT, ingWAT and epiWAT of 7 week old 
mice analyzed by qPCR. Gene expression was normalized to TBP. Graphs show fold difference ± 
SEM (n=3); * p≤0.05, **p≤0.005, ***p≤0.0005.  
(D) Relative mRNA levels of select genes in the adipocyte fraction (AF) and stromal vascular 
fraction (SVF) isolated from the epiWAT of 7 week old mice as analyzed by qPCR. Gene 
expression was normalized to TBP. Graphs show fold difference ± SEM (n=3); * p≤0.05.  
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overall actin expression is enriched in WAT, with α-SMA expression particularly 
biased towards WAT SVF. 
White adipocyte precursor cells have extensive β-actin and α-SMA 
networks  
 Expression aside, we wanted to determine how the actin isoforms 
contribute to the actin cytoskeleton. To examine this, we performed 
immunofluorescence for β-actin and α-SMA in epiWAT SVC (Figure 5.3a) and 
3T3-L1 preadipocytes (Figure 5.3b). We observed that both isoforms were 
present across both cell types and, more importantly, co-localizing with F-actin. 
Curiously, we also observed a pool of β-actin that consistently co-localizes with 
the nucleus of 3T3-L1 preadipocytes. This is unique to 3T3-L1 cells since β-actin 
was not observed in the epiWAT SVC. The immunofluorescence data shows that 
β-actin and α-SMA contribute equally to the F-actin network at subconfluence.  
Significant actin reorganization coincides with the period of hormonal 
induction  
 The stress fibers found in preadipocytes are known to be significantly lost 
during adipogenesis. To determine whether this change is common to both α-
SMA and β-actin isoforms, we observed these isoforms from subconfluence to 
Day 2 in 3T3L-L1 cells (Figure 5.4). As anticipated, F-actin was significantly lost 
by Day 2. The β-actin isoform consistently co-localized with the nucleus as well 
as with F-actin whereas α-SMA only co-localized with F-actin. β-actin appeared 
  A. 
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Figure 5.3 White adipose SVCs have extensive β-actin and α-SMA networks  
(A) Stromal vascular cells (SVC) were plated onto coverslips, fixed and stained for β-actin (top 
row) and α-SMA (bottom row) with Alexa Fluor® 568 Goat Anti-Mouse IgG2a secondary 
antibody. Cells were counterstained with fluorescent Acti-stain 488 phalloidin (F-actin) and DAPI 
for nuclear staining. Bar represents a 50 μm scale.  
(B) 3T3-L1 cells were plated onto coverslips, fixed and stained for β-actin (top row) and α-SMA 
(bottom row) with Alexa Fluor® 568 Goat Anti-Mouse IgG2a secondary antibody. Cells were 
counterstained with fluorescent Acti-stain 488 phalloidin (F-actin) and DAPI for nuclear staining. 
Bar represents a 50 μm scale.   
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Figure 5.4 The actin network is significantly reorganized during hormonal induction  
(A) Stromal vascular cells (SVC) were plated onto coverslips, fixed and stained for β-actin (top 
row) and α-SMA (bottom row) with Alexa Fluor® 568 Goat Anti-Mouse IgG2a secondary 
antibody. Cells were counterstained with fluorescent Acti-stain 488 phalloidin (F-actin) and DAPI 
for nuclear staining. Bar represents a 50 μm scale.  
(B) 3T3-L1 cells were plated onto coverslips, fixed and stained for β-actin (top row) and α-SMA 
(bottom row) with Alexa Fluor® 568 Goat Anti-Mouse IgG2a secondary antibody. Cells were 
counterstained with fluorescent Acti-stain 488 phalloidin (F-actin) and DAPI for nuclear staining. 
Bar represents a 50 μm scale.   
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to co-localize with F-actin and was attenuated by Day 2 (Figure 5.4a). 
Interestingly, α-SMA was significantly downregulated by Day 1 (Figure 5.4b). 
The data suggest a loss in both β-actin and α-SMA occurs during hormonal 
induction (Day 0 to Day 2). The data also sugges the β-actin and α-SMA 
isoforms are not equally regulated during adipogenesis.  
Hormonal induction decreases α-SMA protein levels in both the G-actin and 
F-actin compartment 
 Although both β-actin and α-SMA were observed to contribute to the F-
actin network, the rate at which these fibers are lost appeared to be different as 
indicated by our immunofluorescence data. This prompted us to ask whether 
their contributions to the F-actin and G-actin compartments are different during 
this period of time. To assess this, we performed a series of CSK/RSB 
fractionations during hormonal induction (Figure 5.5). Based on the known loss in 
stress fibers during adipogenesis, we anticipated that the G-actin pool would 
increase as the F-actin pool decreased. Instead, we observed decreases in both 
the G-actin and F-actin pools across all isoforms examined (Figure 5.5a).  There 
was also an earlier loss in the α-SMA F-actin pool relative to the β-actin F-actin 
pool just 3 hours into hormonal induction (Figure 5.5a). Major changes in β-actin 
do not appear until approximately 12 hours into hormonal induction. The γ-actin 
pattern was more similar to that of α-SMA than β-actin with the exception of a 
drop in polymerized γ-actin within 6 hours of hormonal induction.  
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Figure 5.5 Hormonal induction decreases α-SMA protein levels in both the G-actin and F-
actin compartments 
(A) Western blot analysis of 3T3-L1 cells at various points (hours) during hormonal induction. 
Protein was extracted from cells using the CSK/RSB fractionation method. Equal volume fraction 
was loaded in each lane. 
(B) Western blot analysis of total protein harvested from 3T3-L1 cells at various points (days) 
during and following hormonal induction. Equal volume protein was loaded in each lane.  
(C) Western blot analysis of Day2 3T3-L1 treated for two days with either ethanol and 0.1 N 
NaOH (Vehicle) or adipogenic cocktail (DMI). Protein was extracted from cells using the 
CSK/RSB fractionation method. Equal volume fraction was loaded on each lane. 
(D) A graph showing a densiometric analysis of the fold difference in α-SMA and β-actin 
enrichment across CSK (G-actin) and RSB (RSB) fractions in protein extracted from Day 2 3T3-
L1 cells following two days ethanol and 0.1 N NaOH (Vehicle) or adipogenic cocktail (DMI). G-
actin results were normalized to cyclophilin A protein and F-actin results were normalized to 
vimentin protein, (n=3); *p≤0.05.  
 
 
 
92 
To confirm the effect adipogenic cocktail has on the F-actin and G-actin pools, 
we performed a CSK/RSB fractionation on Day 2 3T3-L1 cells treated with either 
adipogenic cocktail or its vehicle (Figure 5.5b). Adipogenic cocktail was found to 
decrease the α-SMA G-actin pool 84% and the F-actin pool 60%, both of which 
were statistically significant. On the other hand, the β-actin G-actin pool fell 31% 
and the F-actin pool, in fact, increased 42% (Figure 5.5c). The changes in β-actin 
were not statistically significant, though. Overall, we can conclude that α-SMA F-
actin, not β-actin stress fibers are lost during hormonal induction.  
 We didn‟t observe net gains in G-actin in proportion with F-actin loss but 
instead observed what appears to be a net loss in α-SMA but not β-actin. To 
confirm this we measured total protein expression during and after hormonal 
induction (Figure 5.5d). The cytoplasmic isoform protein levels slowly and 
steadily decrease whereas α-SMA protein levels drop significantly within the first 
24 hours of hormonal induction. After Day 1, α-SMA protein expression falls to 
near undetectable levels, with a late stage upregulation on Day 8. We can 
conclude that hormonal induction elicits a net loss of actin from both the G-actin 
and F-actin pools. This is not experienced equally across actin isoforms, though. 
The α-SMA isoform is significantly influenced by hormonal induction and its loss 
alone likely accounts for the majority of net actin loss, particularly F-actin loss.  
Actin transcript levels decrease during hormonal induction 
 Although actin protein levels decrease during hormonal induction, it was 
unclear whether decreases were also occurring at the transcript level. We  
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Figure 5.6 Actin levels decrease during hormonal induction 
(A) Relative mRNA levels of actin genes and genes regulated by adipogenesis at various time 
points during 3T3-L1 adipogenesis. Gene expression was normalized to TBP. Graphs show fold 
difference ± SEM (n=4); *p≤0.05, **p≤0.005, ***p≤0.0005. 
(B) Western blot analysis of total protein harvested at various time points during 3T3-L1 
adipogenesis. Equal amounts of protein were loaded per lane.  
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measured actin transcript levels from subconfluence to Day 2 and observed that 
all actin isoforms fall at least 70% (Figure 5.6a). The majority of the drop occurs 
between Days 0 and 2. Although all isoforms drop significantly, the patterns by 
which they achieve the drop are unique. The majority of cytoplasmic isoform 
transcript loss starts at Day 0 while α-SMA transcript levels begin a steady drop 
on Day -2. Transcript levels of γ-actin are transiently induced before they drop on 
Day 0. As experimental controls, PPARγ transcript levels were observed to 
increase and Pref-1 to decrease.  The observed transcript level patterns for each 
actin isoform were largely corroborated by protein level changes (Figure 5.6b).  
Actin transcript is not rendered unstable by adipogenesis 
 The dramatic loss of actin transcript particularly during hormonal induction 
prompted us to wonder whether hormonal induction also decreases the stability 
of actin transcript. To gauge the stability of actin transcript during hormonal 
induction, we performed an actinomycin D decay curve (Figure 5.7). Actinomycin 
 D inhibits RNA polymerase II, and to a lesser extent RNA polymerase III, which 
rapidly stops mRNA transcription (241). Actin transcript was measured during 
hormonal induction of 3T3-L1 cells treated with actinomycin D (Figures 5.7b, and 
5.7d) or its vehicle DMSO (Figure 5.7a and 5.7c). If hormonal induction renders 
actin transcript unstable, then actin transcript levels would continue to drop 
during hormonal induction despite the inclusion of actinomycin D. Kruppel-Like 4 
(KLF4) transcript levels served as a control since KLF4 is known to be transiently 
induced within 3-4 hours of hormonal induction (Figure 5.7d and 5.7e) (242).  
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A.      B. 
      
C.       D. 
         
E.       F. 
       
Figure 5.7 Hormonal induction does not render actin transcript unstable 
Day 0 3T3-L1 cells were pretreated with either  5 μg/mL actinomycin D (B, D, F) or DMSO (A, C, 
E) for 1 hour prior to having adipogenic cocktail of its vehicle, ethanol and 0.1 N NaOH overlayed. 
All the graphs show relative mRNA levels of select genes normalized to TBP. Graphs show fold 
difference ± SEM (n=4).  
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In the absence of actinomycin D and adipogenic cocktail, we observed 
differences in the stability of β-actin and α-SMA transcripts. β-actin transcript was 
stably expressed as indicated by the near zero slope of the curve (Figure 5.7c). 
Interestingly, α-SMA transcript levels were found to decrease. This inherent 
instability corroborates the observed early onset of  α-SMA loss and suggests 
that this isoform is regulated in a manner that β-actin. (Figure 5.6).  
  During hormonal induction, β-actin and α-SMA transcript levels drop at 
similar rates (-0.045 and -0.037 slopes, respectively) (Figure 5.7c). The inclusion 
of actinomycin D nulled the effect of hormonal induction on β-actin (Figure 5.7d) 
and α-SMA (Figure 5.7b) transcripts. We can conclude that neither β-actin nor α-
SMA transcripts are destabilized by adipogenic cocktail. 
IBMX significantly contributes to α-SMA downregulation during hormonal 
induction 
 Although hormonal induction does not render actin transcript unstable, our 
time course data collectively implicate the hormonal induction in the regulation of 
actin. During hormonal induction, cells are treated with an adipogenic cocktail 
consisting of dexamethasone, isobutylmethylxanthine (IBMX) and insulin. We 
examined how actin transcript and protein levels respond to various 
combinations of the adipogenic cocktail (Figure 5.8). Complete adipogenic 
cocktail reduced β-actin transcript levels 70% (Figure 5.8a) and protein levels 
10% (Figure 5.8c) relative to vehicle. No pattern to this downregulation was 
observed with respect to the individual cocktail components. In striking contrast,  
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Figure 5.8 IBMX significantly contributes to α-SMA downregulation during hormonal 
induction 
An analysis of mRNA and protein expression in Day 2 3T3-L1 cells after 48 hours of hormonal 
induction under the specified adipogenic cocktails abbreviated as follows: dexamethasone (D), 
isobutylmethylxanthine (M), insulin (I). Vehicle is ethanol and 0.1 N NaOH. 
(A) Relative mRNA levels of select genes expressed Gene expression was normalized to TBP. 
Graphs show fold difference ± SEM (n=3); *p≤0.05. 
(B) Western blot analysis of total protein extracted. Equal protein was loaded per lane. 
(C) Densiometric analysis of the fold difference in α-SMA and β-actin protein normalized to 
cyclophilin A, (n=3); *p≤0.05,**p≤0.005, ***p≤0.0005. 
(D) Relative mRNA levels of select genes expressed by confluent 3T3-L1 cells treated with 
DMSO and 0.1 N NaOH (Vehicle), 0.5 mM IBMX (IBMX) or 10 μM forskolin (Forskolin) for 48 
hours. Gene expression was normalized to TBP. Graphs show fold difference ± SEM (n=4); 
*p≤0.05.  
 
 
 
98 
α-SMA expression was significantly affected by both cocktail combinations that 
included IBMX. Complete adipogenic cocktail reduced α-SMA transcript levels by 
≥90% (Figure 5.8a) and protein levels by 80% (Figure 5.8c). As long as IBMX 
was included in the cocktail, at least 80% downregulation in α-SMA transcript 
was achieved (Figure 5.8c). IBMX also appeared to negatively regulate the 
expression of γ-actin (Figure 5.8a). The potency and specificity of IBMX was 
verified by its induction of C/EBPβ (Figure 5.7a) (243,244). Of the components of 
the adipogenic cocktail, IBMX had the most influence over actin expression 
particularly over α-SMA.  
  IBMX has two major downstream targets: cyclic nucleotide 
phosphodiesterase and adenosine receptor (245). Cyclic nucleotide 
phosphodiesterases are a large family of enzymes that cleave cAMP and/or  
cGMP to produce the corresponding 5'-nucleotide(246). Inhibiting these enzymes 
increases intracellular cAMP levels. IBMX also inhibits adenosine from binding its 
receptor. Given the known role for cAMP signaling in the induction of adipogenic 
inducers such as C/EBPβ by cAMP response element binding protein (CREB),  
we hypothesized that that pathway likely regulates α-SMA expression as part of 
an adipogenic program (244,247). To test this hypothesis, we treated 3T3-L1 
preadipocytes with either IBMX or forskolin. Forskolin activates adenylate 
cyclase, which synthesizes cAMP from ATP. Both treatments significantly 
attenuated α-SMA transcript (Figure 5.8d) after 48 hour treatment. Neither of the 
cytoplasmic isoforms was dramatically influenced by IBMX nor forskolin 
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treatment. Based on the mirrored effect of the cAMP-inducing agent forskolin, we 
can conclude that IBMX regulates α-SMA expression in 3T3-L1 cells at least in 
part through its ability to induce cAMP levels.  
cAMP signaling regulates α-SMA gene transcription   
 Since IBMX and forskolin significantly reduced α-SMA transcript levels, we 
hypothesized that cAMP signaling was influencing α-SMA transcription. To test 
this hypothesis, we used α-SMA promoter activity in SVCs expressing a 
fluorescent mCherry construct driven by the α-SMA promoter (Figure 5.9). The 
SVCs were treated with IBMX and forskolin and as a control, we overlaid TGFβ 
treatment, which is known to induce α-SMA promoter activity. When we 
measured the fluorescence from individual cells in the field, we found that IBMX 
and forskolin treatment attenuated fluorescence intensity below that of vehicle  
conditions (Figures 5.9a and 5.9b). To confirm that this led to an actual loss in α-
SMA, we measured α-SMA protein (Figure 5.9c) and transcript (Figure 5.9d) 
levels. A drop α-SMA levels in SVC treated with IBMX or forskolin. From the data 
we can conclude that cAMP signaling regulates α-SMA at the level of 
transcription.  
MRTF/SRF activity regulates α-SMA expression in subconfluent 3T3-L1 
cells  
 We  hypothesized that an event preceeding hormonal induction was 
responsible for the falling levels of α-SMA transcript observed leading to            
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Figure 5.9 cAMP signaling downregulates α-SMA gene transcription   
epiWAT SVC with expressing the the Acta2 promoter-mCherry construct were treated with  the 
indicated combinations of 1 nM TGFβ, 0.5 mM IBMX and 10 μM forskolin (FSK) for a combination 
of their vehicles (Veh) (0.1 N NaOH, DMSO, 4 mM TRIS/HCl, 0.2% BSA) for 24 hours. 
(A) A schematic of the Acta2 promoter-mCherry construct along with representative images of 
their mCherry fluorescence 
(B) Graph showing relative mCherry fluorescence fold change in A.U. ± SEM (n=4); *p≤0.05, 
p≤0.005**, p≤0.0005*** 
(C) Western blot of total protein isolates from epiWAT SVC, equal protein loaded per lane 
(D) Relative mRNA levels of select genes expressed epiWAT SVC. Gene expression was 
normalized to TBP. Graph shows fold difference ± SEM (n=4); *p≤0.05, p≤0.005**  
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confluence. Given its known role in the regulation of actin cytoskeleton-
associated genes, the MRTF/SRF transcriptional complex was implicated. To 
determine whether MRTF/SRF regulates actin expression in 3T3-L1 cells, we 
first modulated the expression of MRTFa and measured the effect on actin 
transcript levels (Figure 5.10a and 5.10b). MRTFa knock down with siRNA did 
not change β-actin transcript levels and mildly attenuated γ-actin transcript. The 
α-SMA isoform experienced a 30% decrease in transcript levels in response to a 
60% loss in MRTFa, despite a lack of statistical significance (Figure 5.10a). We 
observed a significant increase in α-SMA transcript and a subtle increase in γ-
actin transcript levels when MRTFa was overexpressed 15-fold (Figure 5.10b). 
By modulating the expression levels of MRTFa, we identified MRTFa as 
specifically regulating the expression of α-SMA and, to a lesser extent γ-actin.  
 To determine the relevance of this observation in the context of 
adipogenesis, we modulated the activity of MRTF/SRF in 3T3-L1 cells. We 
pharmacologically inhibited their activity with CCG-1423, which has been shown 
to bind to the nuclear localization signal of MRTF to ultimately prevent MRTF 
nuclear accumulation and thus inhibit SRF co-activation (248). Cell-cell contact  
has also been reported to inhibit MRTF/SRF activity by driving MRTF out of the 
nucleus (249).  
 Extensive cell-cell contact is experienced by 3T3-L1 cells upon confluence 
or adipogenic Day -2. To test the impact of these two modes of MRTF/SRF 
inhibition on actin expression, we treated subconfluent (low density) and near   
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Figure 5.10 MRTF regulates α-SMA expression in subconfluent 3T3-L1 cells  
3T3-L1 cells were transfected with either eGFP- or MRTFa-specific 30 nM siRNA (A) or eGFP-N1 
or eGFP-MRTFa plasmid (B). Cells were then harvested for total RNA. Relative mRNA levels of 
select genes were measured by qPCR. Gene expression was normalized to TBP. Graphs show 
fold difference ± SEM (n=4); *p≤0.05, **p≤0.005, ***p≤0.0005. 
 (C) 3T3-L1 cells were seeded to 30% density (low) or 90% density (high) and treated with 10 μM 
CCG-1423 for 24 hr. Relative mRNA levels of actin genes and preadipocyte factor 1 (Pref1) at 
various time points during 3T3-L1 adipogenesis. Gene expression was normalized to TBP. 
Graphs show fold difference ± SEM (n=4); *p≤0.05, **p≤0.005. 
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confluent (high density) 3T3-L1 cells with CCG-1423 or its vehicle (DMSO) 
(Figure 5.10c). As a control, we measured the transcript levels of MRTFa, which 
is known to be regulated by MRTF/SRF as part of a feedback loop. We also 
measured the expression of Mical2 which is a speculated MRTF/SRF target gene 
based upon an MRTF ChIP-seq study of 3T3 fibroblasts conducted by Treisman 
and colleagues (250). CCG-1423 treatment attenuated Mical2, MRTFa, γ-actin 
and α-SMA in subconfluent 3T3-L1 cells (Figure 5.10c). High seeding density 
mimicked the attenuation achieved by CCG-1423 but did not potentiate the effect 
of CCG-1423 when combined (Figure 5.10c). Given how α-SMA expression was 
impacted by MRTFa overexpression, knockdown and inactivation, we can 
conclude that MRTFa regulates α-SMA in subconfluent, proliferating 3T3-L1 
cells.  
MRTFa regulates actin expression in SVC  
 To date, we have only achieved partial MRTFa knockdown or inactivation 
of MRTF so to confirm adipogenic actin gene regulation by MRTF/SRF, we 
compared the actin transcript levels of SVC isolated from epiWAT of MRTFA-/- 
and wild type (WT) mice (Figure 5.11)(10). The absence of MRTFa caused a 
70% reduction in α-SMA transcript level, a level that nearly mirrors the level of 
downregulation achieved in Day 1 WT SVC (Figure 5.11a). Based on this 
observation, we can conclude that MRTFa regulates α-SMA during adipogenesis. 
Since the absence of MRTFa caused a 20-30% reduction in β-actin and γ-actin 
transcript levels and their patterns of downregulation in MRTFA-/- SVCs mirrored  
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A. 
 
B.                                                                        
  
Figure 5.11 MRTF regulates actin expression in SVC  
(A) Relative mRNA levels of select genes at various time points epiWAT derived SVC 
adipogenesis. Gene expression was normalized to TBP. Graphs show fold difference ± SEM 
(n=4); *p≤0.05, **p≤0.005. 
 (B) Western blot analysis of total protein isolated from Day -2 and Day 0 epiWAT-derived SVC. 
Equal protein was loaded per lane. 
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those of WT SVCs(Figure 5.11a), we can conclude that MRTFa likely regulates 
these genes as well. During post-confluence (Day -2 to 0), we observed a 
downregulation of α-SMA in WT SVC (Figure 5.11a). As discussed previously, 
this likely coincides with the inactivation of MRTF/SRF in a cell density 
dependent mechanism. To interrogate this further, we examined the period 
between Day -2 and Day 0 at the protein level in WT and MRTFA-/- SVCs (Figure 
5.11b). We found that, indeed, the absence of MRTFa significantly reduced α-
SMA protein levels and lesser so β-actin protein levels. Interestingly, α-SMA 
protein levels still fall between Day -2 and Day 0 despite MRTFa genetic ablation, 
countering observations at the transcript level (Figure 5.11b). We are currently 
repeating with this sufficient mice for statitical analysis to address the disparity in 
RNA versus protein results. 
Discussion 
 As discussed previously, actin cytoskeleton reorganization has been 
described as a loss of long actin filaments during adipogenesis in vitro. Given our 
development of a novel biochemical assay for F-actin/G-actin dynamics, we 
utilized this assay to confirm these findings. We were able to bichemically show 
that there is indeed a net loss in F-actin during early adipogenesis (Figure 5.5a, 
5.5d and 5.5c). Interestingly, we did not observe a complementary increase in G-
actin, but instead a decrease. These results are not surprising when the parallel 
downregulation of actin synthesis and is considered. The matter is further 
complicated by the facts that protein levels can fall as a consequence of 
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decreased  transcription, decreased translation and/or increased degradation. In 
muscle cells, G-actin is degraded by a ubiquitin-proteasoal pathway so it is likely 
that actin must be in the G-actin state to be degraded (251). It is conceivable that 
a similar pathway is working to clear G-actin during adipogenesis as it 
accummulates from F-actin depolymerization.  
 It is also conceivable that we are undervaluing the loss of F-actin by the 
way we quantified the decrease. We normalized RSB-specific actin against 
vimentin which is also downregulated (Figure 5.5b and 5.5c).  We hypothesize 
that normalizing against a more stably expressed protein would numerically 
augment the loss in F-actin. Minor discrepancies aside, the CSK/RSB method 
captured an intriguing aspect of actin dynamics during adipogenesis. At the very 
least, our data suggest that the reorganization of actin impacts both F-actin and 
G-actin. 
 Our studies identified three isoforms relevant to adipogenesis: β-actin, γ-
actin and α-SMA. These isoforms were readily detected in SVC and 3T3-L1 cells 
compared to α-cardiac and α-skeletal muscle isoforms  (data not included). It 
should be noted that γ-smooth muscle actin (γ-SMA) isoform was mildy detected, 
but was still small in magnitude relative to the enrichment of β-actin, γ-actin and 
α-SMA. We observed  that β-actin and α-SMA localized to the polymerized actin 
network as indicated by immunofluorescence (Figure 5.3). We also observed a 
loss in α-SMA stress fibers that correponded with F-actin loss during early 
adipogenesis (Figure 5.4). Curiously, we observed nuclear localization specific to 
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the β-actin isoform. We are currently working towards confirming this result using 
a fluorescently tagged β-actin construct. 
 As adipogenesis progressed, we observed distinctions in the expression 
patterns of the cytoplasmic and α-SMA isoforms. Our results showed that 
although the cytoplasmic isoforms are attenuated and the α-SMA isoform is 
significantly downregulated. These patterns were very similar in two types of 
cells,  3T3-L1s (Figure 5.6a) and SVCs (Figure 5.11a). Our observations were 
corroborated at the level of whole adipose tissue where cytoplasmic isoforms 
were detected in both adipocytes and SVF while α-SMA was enriched in SVF 
(Figure 5.2d). The data suggest that the actin present in the mature adipocyte is 
likely not α-SMA. Mature 3T3-L1 adipocyte cultures, though, expressed levels of 
α-SMA near comparable to the preadipocyte stage (Figure 5.5d). This is likely 
attributable to the layer of undifferentiated 3T3-L1 cells found beneath mature 
adipocytes, similar to a feeder layer. Although we did not explore this hypothesis 
further, a simple comparison of gene expression between adipocyte and feeder 
layer would likely reveal that the α-SMA is limited to the feeder layer.  
 In addition to describing patterns of expression and polymerization, we 
also explored the regulation of actin expression. We identified two stages of 
regulation. Modifying the expression and activity of MRTF/SRF and the genetic 
ablation of MRTFa collectively demonstrated that MRTF regulates actin isoform 
expression during adipogenesis (Figure 5.10 and 5.11). At high density, 
fibroblasts are known to have diminished microfilament polymerization (252). 
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This means that confluence creates a greater G-actin pool which, we 
hypothesize, would be sufficient to sequester MRTF in the cytoplasm. However, 
our data does not indicate that an increase in cytoplasmic G-actin occurs (Figure 
5.5). A growing body of literature indicates a role for nuclear G-actin, not 
cytoplasmic G-actin, in the regulation of MRTF activity (178,253,254). The 
mechanisms regulating nuclear actin are not well known but one major player 
may be Mical2, which, as mentioned, is an MRTF/SRF target gene (254).  
 Our actin fractionation assay is currently not designed to isolate nuclear 
actin. We hypothesize that nuclear actin is isolated with RSB and could be 
overvaluing the magnitude of the RSB fractions. As discussed in Chapter 3, we 
are developing a fractionation assay that will isolate a third, nuclear fraction. If 
net changes in nuclear actin content are what regulate MRTF activity, then the 
assay will be able to detect that. On the other hand, if net changes in nuclear 
actin polymerization are the regulators, which appears to be the case based on 
the literature, then our assay may fall short. Whatever the outcome, these studies 
are relevant given the established role of MRTF/SRF in adipogenesis.  
 Our time courses pointed to a second dramatic stage in actin 
downregulation: hormonal induction. One particular adipogenic cocktail 
component, IBMX, was found to significantly attenuate α-SMA specifically (Figure 
5.8). We confirmed that cAMP signaling was a potent inhibitor of α-SMA 
promoter activity (Figure 5.9). Cyclic AMP has been shown to inhibit α-SMA 
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promoter activity in embryonic stem cells (255). We have shown that this is also 
true in the context of adipogenic differentiation.  
  The distinct stages of isoform-specific regulation, particularly the loss of 
α-SMA, are likely to be more than just a function of adipogenesis. Our data 
suggest that α-SMA, and not β-actin or γ-actin, negatively correlates with 
adipogenesis. We hypothesize that α-SMA plays an important, functional role in 
adipogenesis. This hypothesis is currently being tested in an overexpression 
system, which we predict will have diminished adipogenic potential. If this proves 
to be accurate, then there is reason to believe that α-SMA helps determine the 
competency of a progenitor cell to proceed through adipogenesis. 
 It should be noted that a subtle yet important difference was observed 
between actin expression in 3T3-L1 cells and SVCs, namely that MRTF/SRF 
actin gene regulation was much more limited to α-SMA in 3T3-L1 cells. This may 
be the consequence of two factors. First, the methods by which we modulated 
MRTFa in 3T3-L1 cells were not as robust as the genetic ablation of MRTFa. 
Second, 3T3-L1 preadipocytes are committed to the adipogenic path while SVC 
represents an earlier stage of development. It is possible, then, that MRTF/SRF 
is intrinsically less active and/or expressed less in the preadipocyte cell line 
relative to SVCs. Inhibiting or inactivating MRTF/SRF in 3T3-L1 cells, then, would 
not elicit as dramatic changes in actin as it does in SVC. 
 Overall, these studies have comprehensively described adipogenic actin 
dynamics during early preadipocyte differentiation. We‟ve shown that most of the 
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changes in actin are specific to the α-SMA isoform. We shed light on the 
complexities of adipogenic actin cytoskeletal rearrangement. Our findings point to 
two stages of actin regulation in what we hypothesize is a critical initiation step 
during adipogenesis. 
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CHAPTER SIX 
GENERAL DISCUSSION, FUTUTE DIRECTIONS AND CONCLUSIONS 
DISCUSSION 
 The studies presented in this thesis have characterized the dynamics of 
actin during early adipogenesis, a period marked by morphological and 
transcriptional changes. Similar studies of the relationship between the actin 
cytoskeleton and differentiation have treated actin as a single protein when, in 
fact, it is a family of functionally distinct isoforms. This prompted our investigation 
into the changes of each actin isoform both at the level of expression and at the 
level of spatial organization. In the process of studying actin spatial organization, 
we developed a simple assay for the quantitative description of actin 
polymerization/depolymerization. Using this method, we were able to exclude a 
role for gelsolin the reduction of F-actin. Through these studies, we observed an 
early loss in F-actin without gains in G-actin. We interrogated this further along 
with changes in actin expression to identify unique changes in the α-SMA isoform 
specifically. The implications of these studies are broad and are prompting new 
and interesting directions of research.  
Potential applications for CSK/RSB fractionation 
 Because the polymerized state of actin is influences cell fate, we were 
keenly interested in determining the contributions of each actin isoform to the F-
actin and G-actin pools. To study this, we developed a method for the 
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biochemical assessment of actin dynamics, a method we refer to as CSK/RSB 
fractionation. CSK/RSB fractionation does not replace the use of methods like 
immunostaining of G-actin/F-actin or the expression fluorescently-tagged F-actin 
binding proteins/domains (256). Those methods yield great insight into the 
localization and distribution of actin and, in the case of fluorescent DNAse and/or 
phalloidin, are technically simple to handle for the description of actin dynamics 
on a pan-actin level.  
 Unlike those methods, we have shown that CSK/RSB fractionation can 
assess the polymerization/depolymerization of actin at the level of individual 
isoforms. Broader use of the CSK/RSB fractionation method will require further 
optimization and validation. One source of uncertainty lies in the observed 
nuclear DNAse staining faintly present after CSK incubation (Figure 3.2a and 
3.3a), which suggests CSK does not solubilize all cellular G-actin. Our 
observation is not unorthodox, though. In their description of the use of DNAse 
as a marker for G-actin, Cramer and colleagues tested the sensitivity of DNAse 
by incubating cells in 0.1% Triton X-100 to selectively remove G-actin (257). The 
DNase staining pattern post-incubation revealed a faint, circular stain in the 
region of the nucleus. Our observations are very similar even though we use five 
times the amount of Triton X-100. 
 CSK is not stringent enough to permeabilize the nuclear membrane, so it 
is conceivable that CSK is not solubilizing a nuclear G-actin pool. Recent studies 
have confirmed the presence and relevance of nuclear actin. In the cell types 
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examined, nuclear actin is predominately in the G-actin form (258). An 
accumulation of nuclear β-actin was shown to be involved in regulating 
transcription during macrophage differentiation (259). There is also evidence to 
suggest that nuclear G-actin regulates the export and therefore activity of MRTFa 
(254). We have also observed the β-actin isoform selectively present in the 
nucleus (Figure 5.3a), although this observation requires further confirmation.  
 Concluding that CSK is not solubilizing a pool of nuclear G-actin assumes 
a high level of accuracy on the part of DNAse staining. DNAse nonspecifically 
cleaves DNA to release 5'-phosphorylated di-, tri-, and oligonucleotide products 
(260). A false positive reading within the nucleus, the storage site of DNA, is 
within the realm of possibility. To determine the accuracy of DNAse staining, we 
are currently using actin antibodies instead of DNAse/phalloidin to measure what 
is happening to actin during CSK incubation. We are also tracking isoform-
specific solubility by expressing fluorescently tagged forms of β-actin and α-SMA. 
  Despite the need for further optimization, CSK/RSB fractionation has 
promising applicability particularly in the study of mechanotransduction. Because 
the state of actin polymerization dictates the activity of factors like Taz/Yap and 
MRTF, measuring actin polymerization is invaluable. Our method allows for the 
measurement of changes in both actin polymerization and expression. We were 
able to track the loss of actin and the changes in its polymerization 
simultaneously during early adipogenesis (Figure 5.4a). Our method could be 
used to better describe what happens to G-actin/F-actin when actin expression is 
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increased, too. TGFβ has been shown to induce both actin polymerization and α-
SMA expression (261). These are two intrinsically related events that have not 
been measured simultaneously through biochemical means. Although we can 
anticipate an enrichment of α-SMA in the F-actin pool, it is not clear what effect 
TGFβ has on the G-actin pool once α-SMA levels rise. How G-actin responds 
would have implications on the effect of TGFβ on factors like MRTF.  
 We have also considered the possibility of extending the CSK/RSB 
fractionation to include a third, nuclear fraction. In the extended version, RSB 
incubation is followed by incubation in high-salt, nuclear extraction buffer. The 
remains of the cell monolayer are scraped in that buffer and the lysate is 
sonicated and spun. The supernatant, what we consider the nuclear fraction, has 
been found to selectively contain RNA polymerase II (data not included). We 
anticipate that this method will be a truly novel assay for the parallel tracking of 
actin dynamics and of nuclear factor dynamics, particularly those of MRTF and 
Taz/Yap. 
Cytoplasmic actin and adipogenesis 
 Given how ubiquitous the cytoplasmic isoforms are, it was not surprising 
that we found preadipocytes express both β-actin and γ-actin. These isoforms 
also show similar patterns of expression across adipose depots (Figure 5.2c). 
The mere presence of these isoforms isn‟t compelling but rather their loss and 
the divergence in their patterns of expression. In general, we observed both 
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isoform are downregulated with an earlier losses in γ-actin relative to β-actin 
during adipogenesis (Figure 5.5).  
 The literature suggests that the loss of the cytoplasmic isoforms drives 
Rho/ROCK activity (262,263). In mouse embryonic fibroblasts, the absence of β-
actin leads to impaired migration, increased TGFβ production and increased 
expression of other actin isoforms (262). These phenotypes could be ameliorated 
with Rho/ROCK inactivation. The absence of γ-actin, but not of β-actin, in human 
epithelial cells causes them to adopt a myofibroblast phenotype and also elicits 
Rho/ROCK activation (263). Overall, these isoforms, specifically the lack thereof, 
seem to influence Rho/ROCK activity. 
 We are currently investigating whether similar roles exist for β-actin and γ-
actin in the context of adipogenesis. The absence of the cytoplasmic isoforms in 
those studies caused an induction in the expression of other actin isoforms which 
led to the induction of Rho/ROCK activity. We observed cytoplasmic isoforms 
loss in 3T3-L1 and SVCs which would theoretically mean Rho/ROCK is 
activated. As previously discussed, Rho/ROCK activity inhibits adipogenesis 
which is at odds with the expected outcome of cytoplasmic isoform loss. It is 
probable that because all isoforms are downregulated during adipogenesis, 
Rho/ROCK is not activated and adipogenesis procedes. Better still, the loss of 
both isoforms could help in the inhibition of Rho/ROCK, making these isoforms 
bona fide regulators of adipogenesis. A regulatory role for the cytoplasmic 
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isoforms in adipogenic commitment will be established once stable knockdown 
and overexpression cells lines are established. 
α-SMA and adipogenesis 
 The α-SMA isoform is one of the earliest known proteins expressed during 
the differentiation of smooth muscle cells including mural cells (264). A subset of 
the stromal vasculature cells contains PPARγ+ cells that express no additional 
mature adipocyte markers yet are capable of differentiating into adipocytes in 
vitro. These cells express α-SMA and platelet derived growth factor receptor β 
(PDGFRβ), both markers of the mural cell lineage (61). In human bone marrow-
derived stem cells, knockdown of α-SMA promotes clonogenicity and 
adipogenesis with similar results obtained with sorted α-SMA negative cells 
(265). A recent study profiling WAT-derived UCP-1+ cells identified the 
expression of smooth muscle-specific genes including α-SMA (240). This was not 
true in BAT which is consistent with studies demonstrating that beige adipocytes 
and not brown adipocytes are derived from a mural cell lineage (266). It appears, 
then, that both white and beige adipocytes could originate from a smooth muscle 
cell-like progenitor, making α-SMA expression functionally relevant. 
 We detected α-SMA in both SVC and 3T3-L1 cells and its expression was 
downregulated to near undetectable levels in both cells. This observation was 
initially considered an artifact of cell culture conditions. Growing cells on hard, flat 
surfaces promotes actin polymerization and, likely, more actin expression. Given 
the theories on smooth muscle cell-like origins, it is unlikely that α-SMA 
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expression is an artifact. We hypothesize that the loss of α-SMA expression, 
commits cells to an adipogenic fate. This could be another key moment in 
adipogenic competence. Currently, we are testing this hypothesis through α-SMA 
and β-actin overexpression. We hypothesize that α-SMA overexpression 
specifically will be sufficient to inhibit adipogenesis relative to the effect of β-actin 
overexpression. 
 In our studies, we implicated cAMP signaling in the regulation of α-SMA 
expression during adipogenesis. Downstream of cAMP signaling are two 
proteins: protein kinase A (PKA) and the exchange proteins directly activated by 
cAMP (Epac1 and Epac2). PKA appears to suppress Rho/ROCK activity and 
becomes dispensable for adipogenesis when Rho/ROCK is pharmacologically 
inhibited (267). The anti-adipogenic effect of Rho/ROCK activity was, at the time, 
associated with an inhibitory effect on insulin/insulin-like growth factor 1 
signaling. We now know that Rho/ROCK inactivation is pro-adipogenic because it 
also helps inactivate MRTF/SRF and Taz/Yap activities.  
 Mack and colleagues found that SRF is phosphorylated at T159 by PKA in 
embryonic stem cells. This phosphorylation inhibits smooth muscle cell-specific 
transcription by inhibiting SRF binding to the CArG elements within the promoters 
of smooth muscle cell-specific genes including α-SMA (255). We are currently 
determining whether SRF T159 phosphorylation occurs as a result of hormonal 
induction and whether that is responsible for the expedited loss of α-SMA 
expression. Since MRTF/SRF activity regulates an initial, massive loss in α-SMA 
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expression (Figure 5.6 and 5.11), we hypothesize SRF continues to occupy the 
Acta2 promoter allowing for a low level of α-SMA transcription. Based on 
enhanced rate of α-SMA loss elicited by adipogenic cocktail (Figure 5.6 and 
Figure 5.7a), hormonal induction likely prompts the phosphorylation of SRF by 
PKA, which causes SRF to completely abandon the Acta2 promoter and halt all 
α-SMA transcription. This could help explain why hormonal induction enhances 
the rate of adipogenesis.  
Gelsolin and Taz/Yap 
 Although we found no role for gelsolin in regulating the dynamics of actin 
during hormonal induction, our studies identified the mechanism by which 
gelsolin is induced during adipogenesis. We found that activated glucocorticoid 
receptor is responsible for gelsolin induction in 3T3-L1 cells (Figure 4.4). As 
previously discussed, Taz is transiently downregulated by glucocorticoid during 
hormonal induction and this coincides with gelsolin‟s transient induction by 
dexamethasone (Figure 4.2). In immortalized human mammary epithelial cells, 
gelsolin knockdown has been shown to stabilize Taz expression, promote its 
nuclear localization and drive Taz/Yap target gene expression (165). The 
changes in Taz and gelsolin expression during hormonal induction are likely not 
coincidental. 
 It is believed that gelsolin inhibits Taz/Yap nuclear localization by 
disrupting stress fibers that mechanically prompt Taz/Yap activity. We did not 
observe any changes in the preponderance of stress fibers with the loss of 
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gelsolin (Figure 4.6b), but our measurements were taken at the end of hormonal 
induction. It is possible that F-actin severance by gelsolin is an early, rapid event. 
More likely, the absence of gelsolin and its activity is compensated for by other 
ABPs. The ABP cofilin has been shown to drive pro-adipogenic actin 
depolymerization in a dedifferentiated adipocyte cell line (180). The relationship 
between gelsolin and Taz/Yap may explain gelsolin‟s required expression for 
adipogenic mitotic clonal expansion (MCE). Although a role for Taz/Yap in MCE 
has not been established, the Hippo pathway in yeast is known to serve as a 
checkpoint for mitotic exit, suppressing pro-mitotic Cdk1 (163,268). It possible 
that gelsolin, or F-actin severance in general, is proadipogenic because it 
prevents Taz/Yap from inhibiting MCE. This hypothesis assumes that MCE is 
required for adipogenesis, which remains controversial (269,270).  
Actin in white, beige/brite and brown adipocytes 
 Although 3T3-L1 cells are commonly used to study adipogenesis, they do 
not identify with any one type of adipose probably because they are not derived 
from adipose but instead from disaggregated mouse embryos (110). To address 
this, we also studied actin in SVC and found that the data corroborated data from 
the 3T3-L1 cells. We predominately studied epiWAT SVC because epiWAT 
experiences hyperplasia in response to high fat diet and because we found it to 
be most enriched with actin (Figure 5.2). As mentioned previously, SVCs 
harvested from visceral depots have a lower propensity for adipogenesis. Based 
on our findings and the growing literature, it is possible that visceral WAT SVC do 
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not differentiate as well as subcutaneous WAT because visceral WAT SVCs 
express more α-SMA. 
 Because we observed significant differences in actin and gelsolin 
expression across adipose depots, questions about the variability of the actin 
cytoskeleton in white, brown and beige/brite mature adipocytes is extremely 
relevant. Although there is abundant data about the cortical actin network of the 
white adipocyte no such assessment has been made in brown or beige 
adipocytes. In preliminary experiments, we stained whole WAT and BAT with 
phalloidin and observed differences in intensity and distribution (data not 
included). Because MRTFa drives actin expression and its absence promotes the 
development of beige/brite adipocytes (179), it could reasonably be hypothesized 
that actin is more enriched in white adipose than brown. Although our data 
corroborate this hypothesis (Figure 5.2), the actin cytoskeleton is molded by 
more than just the amount of actin present. 
 White adipocytes are spherical cells with ∼90% of their volume comprised 
of a single cytoplasmic lipid droplet and a „squeezed‟ nucleus while brown 
adipocytes are polygonal cells with a roundish nucleus and several cytoplasmic 
lipid droplets (271). From a morphological perspective, these cells are very 
unique. Because morphology is dictated, in part, by the actin cytoskeleton, it is 
also plausible that brown adipocytes have a more extensive actin cytoskeleton 
network by virtue of not having a volume-consuming, single lipid droplet. The 
hypotheses we‟ve proposed need not be mutually exclusive. As our data 
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suggest, white adipocytes could indeed express more actin but may also 
selectively express a subset of ABPs that maintain a cortical actin network. 
Brown adipocytes, although they express less actin may lack those ABPs and/or 
express ABPs that promote a fibrous actin network. Our observed enrichment of 
gelsolin in WAT fits into this model (Figure 4.1a). A broad screen of ABP 
expression in white, brown and beige adipocytes would shed more light on this 
matter. 
 Differences between the actin cytoskeleton could also be the 
consequence of actin isoform-specific activity of ABPs, a hypothesis inspired by 
a 2005 study of cofilin kinetics. Equilibrium titrations demonstrated an actin 
isoform-dependence of cofilin binding where β-actin filaments are more 
cooperative than α-SMA filaments (272). What this translates into at the level of 
cell biology, is a greater proclivity for β-actin stress fiber severance compared to 
α-SMA stress fiber severance. This is dictated solely by enhanced cooperation 
with cofilin and not enhanced binding by cofilin. It is conceivable that cells rich in 
α-SMA stress fibers could be more susceptible to the actin severing activity of 
cofilin. The enrichment of α-SMA in visceral SVC may therefore allow cofilin to 
cause rapid, dramatic changes in visceral SVC actin cytoskeletons than it can 
achieve in subcutaneous SVCs. These SVCs would not need to express different 
amounts of cofilin to selectively reorganize the actin cytoskeleton and promote 
adipogenesis.  
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Summary 
 In this thesis, a profile of actin during adipogenesis was established at the 
level of the isoform. This profile centered around three actin isoforms: β-actin, γ-
actin and α-SMA. Each isoform showed distinct patterns of expression and 
polymerization. Because actin is both downregulated and reorganized during 
adipogenesis, biochemically describing its dynamics becomes challenging. We 
developed a novel method for the assessment of actin dynamics which allows for 
the use of internal controls for normalization. This makes our method more 
reliable than current kits commercially available on the market. Using this 
method, we observed a rapid loss in α-SMA stress fibers in addition to an earlier 
overall loss in α-SMA. Our studies into the unique changes in α-SMA expression 
and distribution add to the growing body of evidence implicating a smooth muscle 
cell-like origin for adipocytes. They also help create a clearer profile of early step 
adipogenesis. These studies lay the foundation for future studies into whether 
actin directly regulates adipogenic commitment and, if so, how that plays into the 
development of obesity and its related co-morbidities. 
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